Amicus Curiae Brief — Thomas E. Dobbs, State Health Officer of the Mississippi Department of Health, et al., Petitioners v. Jackson Women's Health Organization, et al.

Supreme Court briefSep 20, 2021

Ask Donna

What actually matters in this document.

Text

No. 19-1392

In the

Supreme Court of the United States

THOMAS E. DOBBS, STATE HEALTH OFFICER OF

THE MISSISSIPPI DEPARTMENT OF HEALTH, et al.,

Petitioners,

v.

JACKSON WOMEN’S HEALTH ORGANIZATION, et al.,

Respondents.

On Writ of Certiorari to the United States

Court of A ppeals for the Fifth Circuit

AMICI CURIAE BRIEF OF 547 DEANS,

CHAIRS, SCHOLARS AND PUBLIC HEALTH

PROFESSIONALS, THE AMERICAN PUBLIC

HEALTH ASSOCIATION, THE GUTTMACHER

INSTITUTE, AND THE CENTER FOR U.S.

POLICY, IN SUPPORT OF RESPONDENTS

Edward T. Waters

Counsel of Record

Phillip A. Escoriaza

Rosie Dawn Griffin

Feldesman Tucker Leifer

Fidell LLP

1129 20th Street, N.W.,

Fourth Floor

Washington, D.C. 20036

(202) 466-8960

ewaters@ftlf.com

Counsel for Amici Curiae

307296

i

TABLE OF CONTENTS

Page

TABLE OF CONTENTS . . . . . . . . . . . . . . . . . . . . . . . . . . i

TABLE OF APPENDICES . . . . . . . . . . . . . . . . . . . . . . . iv

TABLE OF CITED AUTHORITIES . . . . . . . . . . . . . . . v

INTEREST OF AMICI CURIAE . . . . . . . . . . . . . . . . . . 1

SUMMARY OF THE ARGUMENT . . . . . . . . . . . . . . . 3

I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

II. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

III. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

ARGUMENT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

I.

Abortion Is An Essential Component Of

The Full Continuum Of Reproductive

Health Care A nd A Basic Means Of

Avoiding The Adverse Health Effects Of

Unintended Pregnancy . . . . . . . . . . . . . . . . . . . . . 5

A. Abortion Plays an Essential Role in

Women’s Health . . . . . . . . . . . . . . . . . . . . . . . 9

B. Abortion Access is Related to Healthy

Pregnancy and Childbirth . . . . . . . . . . . . . 12

ii

Table of Contents

Page

II. Children Of Women Who Experience

Unintended Pregnancies Face Greater

Risks To Life And Health, Including PreTerm Birth, Low Birthweight, And Impaired

Child Development And Well-Being . . . . . . . . . 16

A. Unintended Pregnancy is More Likely

to Result in Pre-Term Birth, Low

Birthweight, and Impaired Development . . 16

B. Children of Women Who Experience

Un i n t e n d e d P r e g n a n c i e s A r e

More Li kely t o Su f fer Adverse

Child Experiences With Lifelong

Consequences . . . . . . . . . . . . . . . . . . . . . . . . 18

1.

Unintended Pregnancy Resulting

in Birth is Associated with Violence

Against Women and Lifelong

Consequences for Children . . . . . . . . . 20

2. Unintended Pregnancy and Birth is

Associated with Greater Parental

Mental Health Challenges and

Lifelong Consequences for Children . 21

3.

Unintended Pregnancy and Birth

is Associated with Elevated Rates

of Death, Divorce, or Separation

and Lifelong Consequences for

Children . . . . . . . . . . . . . . . . . . . . . . . . . 22

iii

Table of Contents

Page

III. Mississippi And Thirteen Other States

With Extensive Abortion Restrictions

Invest The Least In The Health And WellBeing Of Women And Children And Show

The Worst Health Outcomes For Mothers,

Infants And Children . . . . . . . . . . . . . . . . . . . . . 23

A. Certain States, Including Mississippi,

Lead the Nation in the Number

of Abortion Restrictions . . . . . . . . . . . . . . . 25

B. Measures of Health and Health

Investment in Mississippi and Other

High-Restriction States Reveal Deeply

Deficient Safety Net Investments and

Poor Health Outcomes Among Women,

Children, and Families . . . . . . . . . . . . . . . . 26

1.

M at er n a l a nd Ch i ld He a lt h

Indicators in Mississippi and the

Other High-Restriction States

Reveal Poorer Public Health

Outcomes Compared to States with

Greater Abortion Access . . . . . . . . . . . 29

2. Safety Net Investment is Inadequate

in Mississippi and the Other HighRestriction States and Lower

than that in States with Greater

Abortion Access . . . . . . . . . . . . . . . . . . . 31

CONCLUSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34

iv

TABLE OF APPENDICES

Page

Listing of Individual Amici Curiae . . . . . . . . . . . . . . . . 1a

Table 1: States Ranked by Performance on Key

Indicators of Women’s Health, Maternal

Health, and the Health of Infants and Children:

50 States and the District of Columbia . . . . . . . . . 74a

Table 2: State Policies Related to Key Investments

in Health and Health Care Services for Women

of Childbearing Age, Women Who are Pregnant,

Infants, Children, and Families: 50 States and

the District of Columbia . . . . . . . . . . . . . . . . . . . . . . 82a

Table 3: State Rankings Among States Adopting

Seven or More Abortion Restrictions, Including a

Ban at a Specific Gestational Age . . . . . . . . . . . . . . 94a

Table 4: State Policies Among States Adopting

Seven or More Abortion Restrictions, Including

a Ban at a Specific Gestational Age . . . . . . . . . . . . 98a

v

TABLE OF CITED AUTHORITIES

Page

Cases

June Medical Services, LLC v. Russo,

140 S. Ct. 2103 (2020) . . . . . . . . . . . . . . . . . . . . . . . . . 25

Planned Parenthood of Southeastern Pa. v.

Casey,

505 U.S. 833 (1992) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

Whole Women’s Health v. Hellerstedt,

136 S. Ct. 2292, as revised (June 27, 2016) . . . . . . 9, 25

Statutes & Rules

42 U.S.C. § 601 et seq. . . . . . . . . . . . . . . . . . . . . . . . . . . . .29

42 U.S.C. § 1396a(a)(10)(A)(i)(IV) . . . . . . . . . . . . . . . . . . 31

42 U.S.C. § 1396a(a)(10)(A)(i)(VIII) . . . . . . . . . . . . . . . . 32

42 U.S.C. § 1396a(a)(10)(A)(ii)(IX) . . . . . . . . . . . . . . . . . 31

42 U.S.C. § 1396a(a)(10)(A)(ii)(XXI) . . . . . . . . . . . . . . . . 31

42 U.S.C. § 1396a(a)(10)(B)(ii) . . . . . . . . . . . . . . . . . . . . . 31

42 U.S.C. § 1396a(l)(1) . . . . . . . . . . . . . . . . . . . . . . . . . . . 31

42 U.S.C. § 1396a(l)(2) . . . . . . . . . . . . . . . . . . . . . . . . . . . 31

vi

Cited Authorities

Page

42 U.S.C. § 1396a et seq. . . . . . . . . . . . . . . . . . . . . . . . . . 28

42 U.S.C. § 1397 et seq. . . . . . . . . . . . . . . . . . . . . . . . . . . 28

Patient Protection and Affordable Care Act,

Pub. L. 111–48 (Mar. 23, 2010) . . . . . . . . . . . . . . . . . 31

U.S. Sup. Ct. R. 37.6 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1

Other Authorities

Agency for Healthcare Research & Quality,

U.S. D ep t. of H ea lth & Hu m a n S ervs .,

Minority Health: Recent Findings (2013),

https://w w w.ahrq.gov/sites/default /f iles/

w ysiw yg /resea rch /f i nd i ng s /fa ct sheet s /

minority/minorfind/minorfind.pdf . . . . . . . . . . . . . . . . 7

A mirhossein Moaddab et al ., Health Care

Disparity and Pregnancy-Related Mortality

in the United States, 2005–2014, 131 O b .

& G y n . 707 (2018), https://journals.lw w.

com /g reenjou r na l / Fu l lt ex t / 2 018 /0 40 0 0/

Health_Care_Disparity _and_Pregnancy _

Related.15.aspx?sessionEnd=true . . . . . . . . . . . . . . 15

Amy M. Branum & Jo Jones, Trends in Long-Acting

Reversible Contraception Use Among U.S.

Women Aged 15–44, 188 Natl. Ctr. for Health

Stat. Data Brief (2015), https://pubmed.ncbi.

nlm.nih.gov/25714042/ . . . . . . . . . . . . . . . . . . . . . . . . . 6

vii

Cited Authorities

Page

Bradley Corallo & Robin Rudowitz, Analysis

of Recent National Trends in Medicaid

and CHIP Enrollment, K a i s er F a m i ly

Fou n dat ion (2021), https://w w w.kff.org /

coronavirus-covid-19/issue-brief/analysis-ofrecent-national-trends-in-medicaid-and-chipenrollment/ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28

Caitlin Gerdts et al., Side effects, physical health

consequences, and mortality associated

with abortion and birth after an unwanted

pregnancy, 26 Women’s Health Issues 55 (2015),

https://pubmed.ncbi.nlm.nih.gov/26576470/ . . . . . . . 10

Centers for D isease Control & P revention,

Abortion Surveillance (2018), https://perma.cc/

X2KW-MDSA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

CDC, Adverse Childhood Experiences (2020),

https://www.cdc.gov/violenceprevention/aces/

index.html . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18, 20

CDC, Entry into Prenatal Care—United States,

1989 –1997 (2 0 0 0), https: // w w w.cdc.gov/

mmwr/preview/mmwrhtml/mm4918a1.htm . . . . . . . 27

CDC, Health (2019), https://www.cdc.gov/nchs/hus/

index.htm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28

viii

Cited Authorities

Page

CDC, Infant Mortality (2021), https://www.cdc.

gov/reproductivehealth/maternalinfanthealth/

infantmortality.htm . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

C DC , Pl a n n i n g f o r P r e g n a n c y (2 0 2 0),

https://www.cdc.gov/preconception/planning.html . . 12

CDC, Preterm Birth (2020), http://www.cdc.gov/

reproductivehealth/maternalinfanthealth/

pretermbirth.htm . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

CDC, Preventing Adverse Childhood Experiences

(2021), https://www.cdc.gov/violenceprevention/

aces/fastfact.html . . . . . . . . . . . . . . . . . . . . . . 18, 20, 22

CDC, Timing and Adequacy of Prenatal Care in the

United States, 2016 (2018), https://www.cdc.gov/

nchs/data/nvsr/nvsr67/nvsr67_03.pdf . . . . . . . . . . . . 13

Center on Budget & Policy Priorities, Policy Basics:

Temporary Assistance for Needy Families (2021),

https://www.cbpp.org/research/family-incomesupport/temporary-assistance-for-needy-families . . 29

Committee on Natl. Stat., Natl. Research Council,

Estimating Eligibility and Participation for the

WIC Program: Phase I Report (2001), https://

www.ncbi.nlm.nih.gov/books/NBK223572/ . . . . . . . 33

ix

Cited Authorities

Page

C om m i t t ee on U n der s ta n di ng P r em at u r e

B i rt h & A s s u r i ng H e a lt h y O u t c om e s ,

Preter m Bir th: Causes , Consequences ,

and Prevention (Richard E. Behrman &

Adrienne Stith Butler eds., 2007) . . . . . . . . . . . . 16, 17

Commonwealth Fund, 2020 Scorecard on State

Health System Performance, Mississippi (2020),

https://2020scorecard.commonwealthfund.org/

files/Mississippi.pdf . . . . . . . . . . . . . . . . . . . . . . . . . . 30

Data Resource Ctr. for Child & A dolescent

Health, 2018–2019 National Survey of Children’s

Health (2021), https://www.childhealthdata.org/

browse/survey/results?q=4783&r=1&g=606 . . . . . 19

David M. Fergusson et al., Factors Associated with

Reports of Wife Assault in New Zealand, 48

J. M a rri age & F a m . 407 (1986), https://

www.jstor.org/stable/352408 . . . . . . . . . . . . . . . . . . . 20

Diana Cheng et al., Unintended Pregnancy and

Associated Maternal Preconception, Prenatal

and Postpartum Behaviors, 79 Contraception

194 (2009), https://pubmed.ncbi.nlm.nih.gov/

19185672/ . . . . . . . . . . . . . . . . . . . . . . . . . . 10, 13, 14, 21

x

Cited Authorities

Page

Diana Greene Foster et al., Comparison of Health,

Development, Maternal Bonding, and Poverty

Among Children Born After Denial of Abortion

vs After Pregnancies Subsequent to an Abortion,

172 JAMA P ediatrics 1053 (2018), https://

jamanetwork.com/journals/jamapediatrics/

fullarticle/2698454 . . . . . . . . . . . . . . . . . . . . . . . . 12, 22

Diana Greene Foster et al., Effects of Carrying

an Unwanted Pregnancy to Term on Women’s

Existing Children, 205 J. Pediatrics 183 (2019),

https://w w w.jpeds.com/action/showPdf?pii

=S0022-3476%2818%2931297-6 . . . . . . . . . . . . . 18, 22

Diana Green Foster et al., Socioeconomic outcomes

of women who receive and women who are denied

wanted abortions, 108 A m. J. Pub. Health 407

(2018), https://doi.org/10.2105/ajph.2017.304247 . . . 11

Dovile Vilda et al., State Abortion Policies and

Maternal Death in the United States, 2015–

2018 A m. J. P ub. Health e1 (2021), https://

ajph.aphapublications.org/doi/abs/10.2105/

AJPH.2021.306396 . . . . . . . . . . . . . . . . . . . . . . . . 15, 16

Elizabeth G. Raymond & David A. Grimes, The

Comparative Safety of Legal Induced Abortion

and Childbirth in the United States, 119 Ob. &

Gyn. 215 (2012), https://pubmed.ncbi.nlm.nih.gov/

22270271/ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

xi

Cited Authorities

Page

FNS, WIC Eligibility and Coverage Rates

(2018), https://www.fns.usda.gov/wic/eligibilityand-coverage-rates-2018 . . . . . . . . . . . . . . . . . . . . . . 33

FNS , WIC Fr eq u e ntly Ask ed Q u esti o n s

(FAQs) (2019), https://www.fns.usda.gov/wic/

frequently-asked-questions . . . . . . . . . . . . . . . . . . . . 33

Food a nd Nutrition S ervice , U.S. D ept. of

A gr ic u lt u r e , WIC at a Glance (2 013),

https://www.fns.usda.gov/wic/about-wic-glance . . . 29

Guttmacher Institute, Unintended Pregnancy

in the United States (2019), https://w w w.

g uttmacher.org /fact - sheet /u n i nt endedpregnancy-united-states . . . . . . . . . . . . . . . . . . . 5-6, 7

Institute of Medicine, Preventing Low Birthweight

(1985), https://www.ncbi.nlm.nih.gov/books/

NBK214468/ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

Inst. of Med., The Best Intentions: Unintended

Pregnancy and the Well-Being of Children

a n d Fa mi li e s (19 9 5 ), ht t p s: //doi .or g /

10.17226/4903 . . . . . . . . . . . . . . . . . . . . . . . . . . . . passim

Jenna Jerman, Rachel K. Jones & Tsuyoshi Onda,

Characteristics of U.S. Abortion Patients in 2014

and Changes Since 2008, Guttmacher Institute

(2016), https://www.guttmacher.org/report/

characteristics-us-abortion-patients-2014 . . . . . . . . . 9

xii

Cited Authorities

Page

Jennifer A. Hall et al., Pregnancy Intention and

Pregnancy Outcome: Systematic Review and

Meta-Analysis, 21 Maternal & Child Health

J. 670 (2017), https://link.springer.com/article/

10.1007/s10995-016-2237-0 . . . . . . . . . . . . . . . . . . 17, 18

Jessica Houston Su, Pregnancy Intentions

and Parents’ Psychological Well-Being,

74 J. M a r r i a g e & F a m . 118 2 (2 01 2),

https: //on l i nel ibra r y.w i ley.com /doi /abs /

10.1111/j.1741-3737.2012.01006.x . . . . . . . . . . . . . . . . 21

Julia Paradise, Barbara Lyons & Diane Rowland,

Medicaid at 50, Kaiser Family Foundation (2015),

https://www.kff.org/report-section/medicaid-at50-low-income-pregnant-women-children-andfamilies-and-childless-adults/ . . . . . . . . . . . . . . . . . . 28

Julie A. Gazmararian et al., The Relationship Between

Pregnancy Intendedness and Physical Violence

in Mothers of Newborns, 85 Ob. & Gyn. 1031

(1995), https://pubmed.ncbi.nlm.nih.gov/7770250/ . 20

Kai Guterman, Unintended Pregnancy as a

Predictor of Child Maltreatment, 48 Child

A buse & Neglect 160 (2015), https://www.

sciencedirect.com /science/article/abs/pii /

S0145213415001945?casa_token=vb-9lm5FP

J8AAAAA:ncCXeNO6WTPPsQbSwKBBYc

DkOVHKkE34H1I5dcUI4f9-26GQIpeb0C3n

KBSE5TTCvmtJybfH . . . . . . . . . . . . . . . . . . . . . 19, 21

xiii

Cited Authorities

Page

K aiser Fa mily Foundation, Medicaid’s Role

for Women (2 019), https://f iles.k ff.org /

att a ch ment / Fa ct - Sheet -Med ic a ids Role-for-Women . . . . . . . . . . . . . . . . . . . . . . . . . . . 32, 33

K a i s er F a m i ly F ou n da t ion , State Health

Facts, Women’s Health: Women’s Health

In d i c a t o r s : A b o r t i o n S t a t i s t i c s a n d

Policies (2021), https://www.kff.org/statecategory/womens-health/abortion-statisticsand-policies/ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25

Katherine Barton et al., Unplanned pregnancy

and subsequent psychological distress in

partnered women: a cross-sectional study

of the role of relationship quality and wider

social support, 17 BMC Pregnancy Childbirth

44 (2017), https://bmcpregnancychildbirth.

b i o m e d c e n t r a l . c o m / a r t i c l e s / 10 . 1 1 8 6 /

s12884-017-1223-x . . . . . . . . . . . . . . . . . . . . . . . . . . 10-11

Kathleen Green-Raleigh et al., Pregnancy

planning status and health behaviors among

nonpregnant women in a California managed

health care organization, 37 P er s p. on

Sexual & Reprod. health 179 (2005), https://

w w w.guttmacher.org/journals/psrh/2005/

preg nancy-plann ing- st atus-and-hea lthbehaviors-among-nonpregnant-women . . . . . . . . . . 13

xiv

Cited Authorities

Page

Kathryn Kost & Laura Lindberg, Pregnancy

Int enti o n s , Ma t er n a l Beh av i o rs , an d

Infant Health: Investigating Relationships

w i t h Ne w Me a s u r e s a n d Pr o p e n s i t y

Sco re An alysi s, 52 Demogr a ph y 8 3

(2015), https:// link.springer.com /article/

10.1007/s13524-014-0359-9 . . . . . . . . . . . . . . . . . . 14, 17

Kathryn Kost, David J. Landry & Jacqueline E.

Darroch, The Effects of Pregnancy Planning

Status on Birth Outcomes and Infant Care, 30

Persp. On Sexual & Reprod. Health 223 (1998),

https://pubmed.ncbi.nlm.nih.gov/9782045/ . . . . . . . . 14

Kathryn Kost, Unintended Pregnancy Rates at the

State Level: Estimates for 2010 and Trends Since

2002, Guttmacher Institute (2015), https://

www.guttmacher.org/sites/default/files/report_

pdf/stateup10.pdf . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

Kay Johnson et al., Preconception Care to Improve

Pregnancy Outcomes: Clinical Practice

Guidelines, 55 Morbidity & Mortality Wkly. Rev.

1 (2006), https://www.cdc.gov/mmwr/preview/

mmwrhtml/rr5506a1.htm . . . . . . . . . . . . . . . . . . . . . . 13

Kywanna Alfred & Katherine M. Holmes, The

Intersection of Race and Class and the Use

of Long Acting Reversible Contraception

(LARC) a Quantitative Analysis, 133 Ob. &

Gyn. 10S (2019), https://doi.org/10.1097/01.aog.

0000559350.66295.a3 . . . . . . . . . . . . . . . . . . . . . . . . . . 6

xv

Cited Authorities

Page

Laura F. Harris et al., Perceived stress and

emotional social support among women

who are denied or receive abor tions in

the United States: a prospective cohor t

study, 14 BMC Women ’s Health 1 (2014),

https://www.ncbi.nlm.nih.gov/pmc/articles/

PMC4080695/ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .11

Lauren J. Ralph et al., A Prospective Cohort

Study of the Effect of Receiving versus

Being Denied an Abortion on Educational

Attainment, 29 Wom en ’s H ea lt h I s su es

4 5 9 ( 2 01 9) , ht t p s : //d o i . o r g / 10 . 1016 / j .

whi.2019.09.004; https://pubmed.ncbi.nlm.nih.

gov/31708341/ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11

Lawrence B. Finer & Mia R. Zolna, Declines in

Unintended Pregnancy in the United States

2008–2011, 374 New Eng. J. Med. 843 (2016), https://

www.nejm.org/doi/full/10.1056/nejmsa1506575 . . . 6, 7

Law rence B. F i ner et al ., Rea so n s U.S.

Wo m en Have Abo r tio ns: Q u antit ative

and Qualitative, 37 P ersp. on S exua l &

R eprod . H ea lth 110 (2005), https://w w w.

guttmacher.org/journals/psrh/2005/reasonsus-women-have -abor tions- quantit ative and-qualitative-perspectives . . . . . . . . . . . . . . . . . . . . 8

xvi

Cited Authorities

Page

Leah Henke et al., Bar r iers to Obtaining

Long-Acting Reversible Contraception

Among Low-Income Women, 135 O b . &

G y n . 94S (2020), https://doi.org /10.1097/

01.aog.0000664132.19131.2f . . . . . . . . . . . . . . . . . . . . . 6

Lisbet S. Lundsberg, Meredith J. Pensak &

A ileen M. Gariepy, Is Per iconceptional

Substance Use Associated with Unintended

Pregnancy?, 1 Wom en ’s H ea lt h R ep. 17

( 2 0 2 0 ) , h t t p s : // w w w. l i e b e r t p u b . c o m /

doi/10.1089/whr.2019.0006 . . . . . . . . . . . . . . . . . . . . . 13

M. Antonia Biggs, Heather Gould & Diana

G r e e n e Fo s t e r, Un d e r s t a n d i n g w h y

wom en seek abo r tio ns in the U.S., 13

BMC Wom en ’ s H e a lt h 7 (2013) https://

bmc women she a lt h .biome dc ent r a l .c om /

articles/10.1186/1472-6874-13-29 . . . . . . . . . . . . . . . . . 8

Maggie Kirkman et al., Reasons Women Give

for Abortion: A Review of the Literature, 12

Archives of Women’s Mental Health 365 (2009),

https://pubmed.ncbi.nlm.nih.gov/19517213/ . . . . . . . . 8

M arch of D imes , Long-Term Health Effects

of Premature Birth (2019), https://w w w.

m a r c hofd i me s .or g /c ompl ic at ion s / long t er m-hea lth- effects- of-prematu re birth.aspx . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

xvii

Cited Authorities

Page

March of Dimes, Planning Your Pregnancy (2017),

https://www.marchofdimes.org/pregnancy/

planning-your-pregnancy.aspx . . . . . . . . . . . . . . . . . . 5

Mary M. Goodwin et al., Pregnancy intendedness

and physical abuse around the time of

pregnancy: findings from the pregnancy

risk assessment monitoring system, 1996–

1997, 4 M aterna l & C hild H ea lth J. 85

(2000), https://pubmed.ncbi.nlm.nih.gov/

10994576/ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10

Megan L. Kavanaugh & Jenna Jerman, Contraceptive

Method Use in the United States: Trends and

Characteristics Between 2008, 2012 and

2014, 97 Contraception 14 (2017), https://doi.org/

10.1016/j.contraception.2017.10.003 . . . . . . . . . . . . . . . 6

M ississippi Dept. of Health, Miss. Maternal

Mortality Report 2013–2016 5, 25 (Mar. 2021),

https://perma.cc/H362-RN2Q . . . . . . . . . . . . . . . . . 9-10

N at l . A ca d . of S ci enc e s , E ngi n eer i ng &

M e dic i n e , Th e Safety an d Q u a lity of

Abortion Care in the United States (2018),

https://w w w.nap.edu /catalog /2 4950/the sa fety-a nd- qua l ity- of-abor t ion- ca re -i nthe-united-states . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

xviii

Cited Authorities

Page

Natl . C a ncer I nstit u t e , Natl . I nstit u t es

of H e a lt h , D i c ti o n a r y of Ca n c e r

Ter m s (2 0 21), https: // w w w.c a ncer.gov/

publications/dictionaries/cancer-terms/def/

low-birth-weight . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

Natl. Ctr. for Transgender Equality, 2015 U.S.

Transgender Survey Executive Summary

(2016), https://transequality.org/sites/default/

files/docs/usts/USTS-Executive-SummaryDec17.pdf . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3, 5

Nazli Baydar, Consequences for Children of Their

Birth Planning Status, 27 Family Planning Persp.

228 (1995), https://www.jstor.org/stable/2136174 . 18, 19

Pamela Herd et al., The Implications of Unintended

Pregnancies for Mental Health in Later Life,

106 A m. J. Pub. Health 421 (2016), https://www.

ncbi.nlm.nih.gov/pmc/articles/PMC4815713/pdf/

AJPH.2015.302973.pdf . . . . . . . . . . . . . . . . . . . . . . . . 21

Prakesh S. Shah et al., Intention to Become

Pregnant and Low Birth Weight and Preterm

Birth: A Systematic Review, 15 Maternal &

Child Health J. 205 (2011), https://pubmed.

ncbi.nlm.nih.gov/20012348/ . . . . . . . . . . . . . . . . . . . . 16

xix

Cited Authorities

Page

Rachel K. Jones & Jenna Jerman, Abortion

Incidence and Service Availability in the

United States, 2017, 49 Persp. on S exual

& R e p r o d . H e a lt h 17 (2 017 ), ht t p s: //

w w w. g ut t m a c he r.or g / r ep or t /ab or t ion incidence-service-availability-us-2017 . . . . . . . . . . . 26

Rachel K. Jones, Reported Contraceptive Use

in the Month of Becoming Pregnant Among

U.S. Abortion Patients in 2000 and 2019,

97 Contraception 309 (2018), https://www.

guttmacher.org/article/2018/01/reportedcont racept ive -use -month-becom i ngpregnant-among-us-abortion-patients-2000 . . . . . . . 7

Russell S. Kirby & Sarah Verbiest, Kotch’s Maternal

and Child Health: Programs , Problems and

Policy in Public Health (4th ed. 2021) . . . . . . . . . . 27

Samantha Artiga et al., Racial Disparities

i n Ma t e r n a l a n d Inf a n t He a l t h : An

Overview, K aiser Family Foundation (2020),

https://w w w.kff.org/report-section/racialdisparities-in-maternal-and-infant-health-anoverview-issue-brief/ . . . . . . . . . . . . . . . . . . . . . . . . . 15

xx

Cited Authorities

Page

Sara Roberts et al., Risk of violence from

the man involved in the pregnancy after

receiving or being denied an abor tion,

1 2 BMC M e d . 14 4 ( 2 0 14 ) , h t t p s : / /

bmcmedicine.biomedcentral.com/articles/

10.1186/s12916-014-0144-z . . . . . . . . . . . . . . . . . . . . . 10

Sarah K.G. Jensen & Theresa S. Betancourt,

Recognizing the Complexity of Psychosocial

Fa c t o r s A s s o c i a t e d Wi t h C h i l d r e n’s

De v el o p m e n t —T h e Ca se of Ma t e r n a l

Dep ression, 4 JA M A Ne t wor k O p en 1

(2 0 21), doi :10 .10 01 / ja m a net workop e n .

2021.22310 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21-22

Sa rah Miller, Laura R . W her r y & Diana

Greene Foster, The Economic Consequences

of Be in g De ni e d a n Ab o r ti o n , N a t l .

B. E con . R esea rch (2020), https://w w w.

nber.org /syst em /f i les / work i ng _ papers /

w26662/w26662.pdf . . . . . . . . . . . . . . . . . . . . . . . . 11-12

S elect P a nel for the P romotion of C hild

Health , Better Health for Our Children:

A National Strategy, Report to the United

States Congress and the Secretary of Health

& Human Ser vs. (1981), https://catalog.

hathitrust.org/Record/000200804 . . . . . . . . . . . . . . 28

xxi

Cited Authorities

Page

S t e p h a n i e Ho l t e t a l ., T h e Im p a c t O f

E x p o s u r e To D o m e s t i c V i o l e n c e O n

Children And Young People: A Review

Of Th e Literature, 32 C h i l d A bu s e &

Neglect 797 (2008), https://doi.org/10.1016/

j.chiabu.2008.02.004 . . . . . . . . . . . . . . . . . . . . . . . . . . 21

Steven Carlson et al., WIC Participation and Costs

are Stable, Center on Budget & Policy Priorities

(2017), https://www.cbpp.org/research/foodassistance/wic-participation-and-costs-are-stable . . 34

Susan J. Zuravin, Unplanned Childbearing and

Family Size: Their Relationship to Child Neglect

and Abuse, 23 Family Planning Persp. 155 (1991),

https://www.jstor.org/stable/2135738 . . . . . . . . . . . . 19

Ted Joyce , Rob er t K a e st ner & S a nder s

Korenman, The Stability of Pregnancy

Intentions and Pregnancy-Related Maternal

Behaviors, 4 M aterna l & C hild H ea lth

J. 171 (2020), https://w w w.researchgate.

net/publication/12229447_The_Stability _

of_Pregnancy_Intentions_and_PregnancyRelated_Maternal_Behaviors . . . . . . . . . . . . . . . . . . 13

U.S. Dept. of Health & Human Servs., Annual

Update of the HHS Poverty Guidelines, 86 Fed.

Reg. 7733 (Feb. 1, 2021) . . . . . . . . . . . . . . . . . . . . . 7, 27

xxii

Cited Authorities

Page

United Health Foundation, America’s Health

Rankings: Unintended Pregnancy (2021),

https://w w w.americashealthrankings.org/

ex plore / hea lth- of-women-a nd- chi ld ren /

measure/unintended_pregnancy/state/U.S . . . . . . . 24

Ushma D. Upadhyay, M. Antonia Biggs & Diana

Greene Foster, The effect of abortion on

having and achieving aspirational one-year

plans, 15 BMC Women ’s H ealth 6 (2015),

https://bmcwomenshealth. biomedcentral.com/

articles/10.1186/s12905-015-0259-1 . . . . . . . . . . . . . . 11

1

INTEREST OF AMICI CURIAE 1

The 547 individual Amici are Deans, Chairs, Scholars,

and Public Health Professionals appearing in their

individual capacities. They include many of the nation’s

leading academic scholars and research experts in public

health, reproductive health, and health policies that affect

the nation’s most vulnerable, at-risk populations. Their

collective expertise focuses on low-income people, including

women, children, and families who experience heightened

health threats and systemic barriers to essential health

care services, including to reproductive health care. Amici

include many public health professionals who work directly

with medically underserved communities and have frontline and first-hand experience with the risks and barriers

these populations confront daily. The full list of individual

Amici Curiae Deans, Chairs, Scholars, and Public Health

Professionals is printed in an appendix to this brief.

The American Public Health Association (“APHA”) is

an organization of nearly 25,000 public health professionals

and a nearly 150-year perspective that champions the

health of all people and all communities, strengthens

the profession of public health, shares research and

information, promotes best practices, and advocates for

public health issues and policies grounded in scientific

research. APHA has long recognized that access to the

full range of reproductive health services, including

1. Pursuant to Supreme Court Rule 37.6, Amici certify that

no party or counsel for a party authored this brief in whole or in

part, and no party other than Amici or their counsel contributed

money intended to fund the preparation or submission of the brief.

The parties respectively filed blanket written consent to the filing

of amicus curiae briefs, in support of either party or neither party.

2

abortion, is a fundamental right integral to the health and

well-being of individual women and to the broader public

health. APHA opposes restrictions that (1) deny, delay, and

impede access to abortion services, therefore increasing

women’s risk of injury or death, and (2) coerce women to

carry unintended pregnancies to term.

The Guttmacher Institute is a leading research and

policy organization committed to advancing sexual and

reproductive health and rights worldwide. The Institute

generates data and analysis to defend and advance people’s

ability to access the full range of sexual and reproductive

health care—including safe, legal, and affordable

abortion—with a particular focus on addressing historical

and ongoing oppressions due to race, gender, sexuality,

income, age, or immigration status. Guttmacher produces

high quality data that inform evidence-based policies and

demonstrate the harms caused by ideologically-motivated

abortion restrictions and the clear violation of basic human

rights such restrictions represent.

The Center for U.S. Policy (“CUSP”) is a nonpartisan,

not-for-profit research and education organization

dedicated to enhancing the health, safety, and economic

opportunity of all Americans. CUSP’s work is premised

on and promotes the values of freedom, responsibility,

and compassion. CUSP’s priorities include protecting

the rights of health care providers to exercise their

professional discretion in treating patients and opposing

governmental interference in health care decision making.

3

SUMMARY OF THE ARGUMENT

I.

The ability to safely and legally terminate a pregnancy

is both an individual constitutional right and a public

health concern. Abortion is an essential component of

reproductive health. Despite major advances in birth

control, nearly half of women2 who experience unintended

pregnancies (including both mistimed and unwanted

pregnancies) were attempting to prevent pregnancy

with contraception. Compared to those that are planned,

unintended—and particularly unwanted—pregnancies

carry far greater health risks.

A ny ba n on pre -v iabi l ity abor t ion — such a s

Mississippi’s, which bans nearly all abortions greater

than fifteen weeks into pregnancy and provides no

exceptions for rape or incest—carries major public

health implications because it forces women to carry

pregnancies to term under adverse circumstances marked

by substantially greater risks to their health and that of

their families. Of particular concern to Amici, any ban

will disproportionately affect young women, women of

color, and low-income women who live in families and

2. Although this brief refers to women throughout, Amici

recognize that the public health interest lies in protecting all people

who may become pregnant; Amici accordingly underscore the major

risks a ban would impose on people who, although born female,

identify as non-binary or male. Indeed, the rate of sexual assault

against transgender men is shockingly high. See Natl. Ctr. for

Transgender Equality, 2015 US Transgender Survey Executive

Summary (2016) at 13, https://transequality.org/sites/default/files/

docs/usts/USTS-Executive-Summary-Dec17.pdf.

4

communities already vulnerable to elevated health and

social risks and reduced access to necessary health care.

II.

The public health risks of forcing women to carry

unintended, and especially unwanted, pregnancies to

term, wash over families. Elevated risks to life, health,

and well-being include maternal mortality, prematurity,

infant mortality, developmental difficulties, and increased

likelihood of exposure to significant traumas, whose

lifelong, adverse physical and mental health effects trigger

intergenerational harm.

III.

A wealth of evidence demonstrates a central paradox:

fourteen of the states with the nation’s most restrictive

abortion laws, including Mississippi, invest the least in

policies and programs of proven importance and value

to the health and well-being of women, children, and

families. Mothers, infants, and children in these fourteen

states also experience the worst health outcomes, as

revealed by key indicators of maternal and child health.

Indeed, one leading study of state-level population health

ranks Mississippi last in the nation on a composite score

consisting of measures that include infant mortality,

preventable deaths, and children without age-appropriate

medical and dental preventive health care visits in the

past year.

ARGUMENT

Mississippi’s unconstitutional pre-viability abortion

ban threatens the public health in Mississippi and beyond.

5

Mississippi seeks to force women3 to forgo a recognized

and fundamental constitutional right to control their own

health and to make for themselves and their families—in

consultation with their chosen health professional—the

most intimate and personal choices free from state

interference. Cf. Planned Parenthood of Southeastern Pa.

v. Casey, 505 U.S. 833, 846–47 (1992). The near total ban

Mississippi seeks to impose before viability contravenes

settled constitutional law and disregards the significant

burdens and multiple public health risks this ban creates.

Amici urge this Court to affirm the Fifth Circuit’s

rejection of Mississippi’s law as unconstitutional.

I.

Abortion Is An Essential Component Of The Full

Continuum Of Reproductive Health Care And

A Basic Means Of Avoiding The Adverse Health

Effects Of Unintended Pregnancy

Abortion access is an essential component of

reproductive health care critical to public health. A core

principle of public health is that maternal and child

health are closely associated with women’s ability to

plan their pregnancies. See M arch of Dimes, Planning

Your Pregnancy (2017), https://www.marchofdimes.org/

pregnancy/ planning-your-pregnancy.aspx. Yet in 2011,

forty-five percent of U.S. pregnancies (2.8 million out of

6.1 million) were unintended, meaning they were either

mistimed—occurring when a woman did not, at that time,

desire to be pregnant—or unwanted— occurring when a

woman did not, at that time, or at any future point, desire

to be pregnant. Guttmacher I nstitute, Unintended

Pregnancy in the United States (2019), https://www.

3. See n.2, supra regarding Amici’s use of the term “women.”

6

guttmacher.org/fact-sheet/unintended-pregnancy-unitedstates; Lawrence B. Finer & Mia R. Zolna, Declines in

Unintended Pregnancy in the United States 2008–2011,

374 New Eng. J. Med. 843, 843 (2016), https://www.nejm.

org/doi/full/10.1056/nejmsa1506575.

Forcing women to carry unintended, and especially

unwanted, pregnancies to term negatively affects health.

Without the option of abortion, women lose the ability to

plan their lives and to maximize opportunities for better

health for themselves and their families.

Steadily over the decades, the proportion of women

seeking abortion has declined as availability and use

of the most effective forms of contraception has risen.

See Finer & Zolna, supra; Amy M. Branum & Jo Jones,

Trends in Long-Acting Reversible Contraception Use

Among U.S. Women Aged 15–44, 188 Natl. Ctr . for

Health Stat. Data Brief (2015), https://pubmed.ncbi.

nlm.nih.gov/25714042/; see also Megan L. Kavanaugh &

Jenna Jerman, Contraceptive Method Use in the United

States: Trends and Characteristics Between 2008, 2012

and 2014, 97 Contraception 14, 17 (2017), https://doi.

org/10.1016/j.contraception.2017.10.003.4 Still, fifty-one

percent of women who terminated their pregnancies

4. Poor women and women of color have less access to the most

effective family planning methods. Leah Henke et al., Barriers to

Obtaining Long-Acting Reversible Contraception Among LowIncome Women, 135 Ob. & Gyn. 94S (2020), https://doi.org/10.1097/01.

aog.0000664132.19131.2f; Kywanna Alfred & Katherine M. Holmes,

The Intersection of Race and Class and the Use of Long Acting

Reversible Contraception (LARC) a Quantitative Analysis, 133 Ob.

& Gyn. 10S (2019), https://doi.org/10.1097/01.aog.0000559350.66295.

a3.

7

had used contraceptives during the month in which they

conceived. Rachel K. Jones, Reported Contraceptive Use

in the Month of Becoming Pregnant Among U.S. Abortion

Patients in 2000 and 2019, 97 Contraception 309, 310

(2018), https://w w w.guttmacher.org/article/2018/01/

reported-contraceptive-use-month-becoming-pregnantamong-us-abortion-patients-2000. For this and other

reasons, safe, legal abortion is a vital component of the

reproductive health continuum.

Poverty, youth, and minority racial status, each

standing alone, increases the risk of unintended pregnancy.

Guttmacher Institute, Unintended Pregnancy in the

United States, supra. Low-income women, i.e. those

with incomes below 200 percent of the federal poverty

level (“FPL”), 5 experience unintended pregnancy rates

significantly higher than those who are not low-income;

among women living below FPL, the unintended

pregnancy rate is five times higher than that experienced

by higher-income women. Finer & Zolna, supra, at 846.

The racial demography of poverty in the United States

means that low-income women are also disproportionately

women of color. Women who fall into one or more of these

often-overlapping categories are uniquely vulnerable

to deep poverty, health risk exposure, and health care

exclusion and discrimination. See generally, Agency for

H ealthcare Research & Quality, Minority Health:

Recent Findings (2013), https://www.ahrq.gov/sites/

default/files/wysiwyg/research/findings/factsheets/

5. The federal poverty level in the 48 contiguous states and

the District of Columbia stands at $12,880 in 2021 for individuals

and at $17,420 for a family of 2. See U.S. Dept. of Health & Human

Servs., Annual Update of the HHS Poverty Guidelines, 86 Fed.

Reg. 7733 (Feb. 1, 2021).

8

minority/minorfind/minorfind.pdf. These women and their

families would bear the brunt of an abortion ban.

Women recognize the vital importance of planned

pregnancy. Those who seek pre-viability 6 abortion

overwhelmingly do so because they decide that abortion

is the best choice for their health and well-being and that

of their families, including children already in their care.

See Lawrence B. Finer et al., Reasons U.S. Women Have

Abortions: Quantitative and Qualitative, 37 Persp. on

Sexual & Reprod. Health 110, 112 (2005), https://www.

guttmacher.org/journals/psrh/2005/reasons-us-womenhave-abortions-quantitative-and-qualitative-perspectives;

see also Maggie Kirkman et al., Reasons Women Give

for Abortion: A Review of the Literature, 12 A rchives of

Women’s Mental Health 365 (2009), https://pubmed.ncbi.

nlm.nih.gov/19517213/; M. Antonia Biggs, Heather Gould

& Diana Greene Foster, Understanding why women

seek abortions in the U.S., 13 BMC Women’s Health

7 (2013) https://bmcwomenshealth.biomedcentral.com/

articles/10.1186/1472-6874-13-29) (finding nearly thirty

percent of women cite needing to care for other children

as a primary reason for seeking abortion).

Unintended, and especially unwanted, pregnancies

carry major short- and long-term health risks. The fallout

from preventing women from terminating unintended

pregnancies washes over women and their families,

including the children they already have; indeed, nearly

sixty percent of women seeking abortion already have

6. Pre-viability abortion is generally understood to mean

termination of pregnancy at a point at which survival outside the

uterus is impossible or extremely unlikely.

9

children. Jenna Jerman, Rachel K. Jones & Tsuyoshi

Onda, Characteristics of U.S. Abortion Patients in 2014

and Changes Since 2008, Guttmacher Institute (2016),

https://www.guttmacher.org/report/characteristics-usabortion-patients-2014. Conversely, the ability to plan a

pregnancy allows women to optimize their own health

outcomes and those of their families.

A.

Abortion Plays an Essential Role in Women’s

Health

Abortion, especially pre-viability, is among the

safest medical procedures. See Natl. Acad. of Sciences,

Engineering & M edicine , The Safety and Quality

of Abortion Care in the United States (2018), https://

www.nap.edu/catalog/24950/the-safety-and-quality-ofabortion-care-in-the-united-states. Legal abortion is

markedly safer than childbirth: nationally, health risks

associated with childbirth are fourteen times greater than

risks associated with abortion. Elizabeth G. Raymond

& David A. Grimes, The Comparative Safety of Legal

Induced Abortion and Childbirth in the United States,

119 O b. & Gyn. 215, 216 (2012), https://pubmed.ncbi.

nlm.nih.gov/22270271/; accord Whole Women’s Health

v. Hellerstedt, 136 S. Ct. 2292, 2315, as revised (June

27, 2016); see also Centers for Disease C ontrol &

Prevention, Abortion Surveillance (2018), https://perma.

cc/X2KW-MDSA (reporting 0.44 deaths per 100,000

legally induced abortions in the United States from

2013–2017). Particularly of note, risks are substantially

greater in Mississippi, where it is approximately seventyfive times more dangerous for women to carry a pregnancy

to term than to have an abortion. See Mississippi Dept. of

Health, Miss. Maternal Mortality Report 2013–2016 5,

10

25 (2021), https://perma.cc/H362-RN2Q (reporting 33.2

pregnancy-related deaths per 100,000 live births).

Bir ths involving unintended preg nancies are

associated with a host of adverse health and social

outcomes for women, and ultimately, their families.

Women who carry unintended, and especially unwanted,

pregnancies to term are more likely to experience a wide

range of adverse health outcomes including depression,

poor birth outcomes, interpersonal violence, and

psychological distress. Compared to those able to obtain

abortions, women who are denied abortions are also

subsequently more likely to live in poverty, more likely to

lack financial supports critical to better health outcomes,

such as housing and nutrition, and more likely to raise

their children alone. See Diana Cheng et al., Unintended

Pregnancy and Associated Maternal Preconception,

Prenatal and Postpartum Behaviors, 79 Contraception

194, 195 (2009), https://pubmed.ncbi.nlm.nih.gov/19185672/;

Mary M. Goodwin et al., Pregnancy intendedness and

physical abuse around the time of pregnancy: findings

from the pregnancy risk assessment monitoring system,

1996–1997, 4 M aternal & Child Health J. 85–92 (2000),

https://pubmed.ncbi.nlm.nih.gov/10994576/; Caitlin Gerdts

et al., Side effects, physical health consequences, and

mortality associated with abortion and birth after an

unwanted pregnancy, 26 Women’s Health Issues 55–59

(2015), https://pubmed.ncbi.nlm.nih.gov/26576470/; Sara

Roberts et al., Risk of violence from the man involved

in the pregnancy after receiving or being denied an

abortion, 12 BMC Med. 144 (2014), https://bmcmedicine.

biomedcentral.com/articles/10.1186/s12916-014-0144-z;

Katherine Barton et al., Unplanned pregnancy and

subsequent psychological distress in partnered women:

11

a cross-sectional study of the role of relationship quality

and wider social support, 17 BMC Pregnancy Childbirth

44 (2017), https://bmcpregnancychildbirth.biomedcentral.

com/articles/10.1186/s12884-017-1223-x; Diana Green

Foster et al., Socioeconomic outcomes of women who

receive and women who are denied wanted abortions, 108

A m. J. Pub. Health 407–13 (2018), https://doi.org/10.2105/

ajph.2017.304247.

Conversely, the ability to plan pregnancy and

childbirth is positively associated with health and wellbeing. Women able to obtain an abortion they seek

are subsequently more likely to have and achieve an

aspirational life plan compared to women who sought

abortion but were turned away. Ushma D. Upadhyay,

M. Antonia Biggs & Diana Greene Foster, The effect of

abortion on having and achieving aspirational oneyear plans, 15 BMC Women’s Health 6 (2015), https://

bmcwomenshealth.biomedcentral.com/articles/10.1186/

s12905-015-0259-1. They are also significantly more likely

to complete a postsecondary degree. Lauren J. Ralph et

al., A Prospective Cohort Study of the Effect of Receiving

versus Being Denied an Abortion on Educational

Attainment, 29 Women’s Health Issues 459 (2019), https://

doi.org/10.1016/j.whi.2019.09.004; https://pubmed.ncbi.

nlm.nih.gov/31708341/.

Such women also report lower stress levels and

better financial well-being in the years after obtaining

an abortion. Laura F. Harris et al., Perceived stress and

emotional social support among women who are denied

or receive abortions in the United States: a prospective

cohort study, 14 BMC Women’s Health 1–11 (2014), https://

www.ncbi.nlm.nih.gov/pmc/articles/PMC4080695/; Sarah

12

Miller, Laura R. Wherry & Diana Greene Foster, The

Economic Consequences of Being Denied an Abortion,

Natl. B. Econ. Research (2020) at 3, https://www.nber.

org/system/files/working_papers/w26662/w26662.pdf

(abortion denial increases amount of debt thirty days or

more past due by seventy-eight percent and increases

negative public records, such as bankruptcies and

evictions, by eighty-one percent); see also Diana Greene

Foster et al., Comparison of Health, Development,

Maternal Bonding, and Poverty Among Children Born

After Denial of Abortion vs After Pregnancies Subsequent

to an Abortion, 172 JAMA Pediatrics 1053, 1058 (2018),

https://jamanetwork.com /journals/jamapediatrics/

fullarticle/2698454 (finding women denied abortions

significantly less likely to be employed full time, with no

analytic group differences in receipt of public assistance).

B. Abor tion Access is Related to Healthy

Pregnancy and Childbirth

Several important influences on maternal and child

health flow from ensuring that women are able to plan a

birth. First, planning a birth means being able to enter

pregnancy in the best health possible. See Centers for

Disease Control & Prevention (hereinafter “CDC”),

Planning for Pregnancy (2020), https://www.cdc.gov/

preconception/planning.html (noting pre-conception

care optimizes overall health and allows for physical

and behavioral risk mitigation). Where pregnancy is

unintended, women lack early opportunities to make

lifestyle changes before becoming pregnant and giving

birth. Women who experience an unintended pregnancy

may have lived their lives in all the normal ways people do

when pregnancy is not planned. They may drink alcohol,

13

smoke, or manage a health condition with medication

that is contraindicated in pregnancy. See Kay Johnson

et al., Preconception Care to Improve Pregnancy

Outcomes: Clinical Practice Guidelines, 55 Morbidity

& Mortality Wkly. Rev. 1–23 (2006), https://www.cdc.

gov/mmwr/preview/mmwrhtml/rr5506a1.htm; Kathleen

Green-Raleigh et al., Pregnancy planning status and

health behaviors among nonpregnant women in a

California managed health care organization, 37 Persp.

on Sexual & Reprod. health 179, 181 (2005), https://www.

guttmacher.org/journals/psrh/2005/pregnancy-planningstatus-and-health-behaviors-among-nonpregnant-women;

see also Lisbet S. Lundsberg, Meredith J. Pensak &

Aileen M. Gariepy, Is Periconceptional Substance Use

Associated with Unintended Pregnancy?, 1 Women ’s

Health Rep. 17, 19–20 (2020), https://www.liebertpub.com/

doi/10.1089/whr.2019.0006; Ted Joyce, Robert Kaestner

& Sanders Korenman, The Stability of Pregnancy

Intentions and Pregnancy-Related Maternal Behaviors,

4 M aternal & Child Health J. 171–78 (2020), https://

w w w.researchgate.net/publication /12229447_The_

Stability _of_Pregnancy _Intentions_and_PregnancyRelated_Maternal_Behaviors; Cheng et al., Unintended

Pregnancy, supra.

Second, when pregnancy is planned, comprehensive

prenatal care—access to which is a major determinant

of women’s and infants’ health— is especially likely to

begin early. CDC, Timing and Adequacy of Prenatal

Care in the United States, 2016 (2018), https://www.cdc.

gov/nchs/data/nvsr/nvsr67/nvsr67_03.pdf. Women with

unintended, and particularly unwanted, pregnancies

are far less likely to receive adequate and timely

prenatal care, which subsequently places them and

14

their infants at greater risk for poor health outcomes.

See Kathryn Kost, David J. Landry & Jacqueline E.

Darroch, The Effects of Pregnancy Planning Status on

Birth Outcomes and Infant Care, 30 Persp. On Sexual

& Reprod. Health 223, 223 (1998), https://pubmed.ncbi.

nlm.nih.gov/9782045/ (noting women with unintended

pregnancies less likely to recognize pregnancies within

first six weeks of conception and significantly less likely

than those who planned pregnancies to receive care

in first eight weeks). Extensive research documents

the link between unintended pregnancy and late entry

into prenatal care, inadequate prenatal care, and poor

maternal and infant health outcomes. See generally,

Institute of Medicine, The Best Intentions: Unintended

Pregnancy and the Well-Being of Children and Families

(1995), https://doi.org/10.17226/4903. Indeed, nearly all

peer-reviewed studies find a strong relationship between

unintended pregnancy and late entry into prenatal care,

and an even stronger relationship among women with

unwanted pregnancies. Id. at 66; see also Cheng et al.,

Unintended Pregnancy, supra at 196 (finding mothers

with unwanted pregnancies less likely to receive prenatal

care during the first trimester, compared to women with

intended pregnancies); Kathryn Kost & Laura Lindberg,

Pregnancy Intentions, Maternal Behaviors, and Infant

Health: Investigating Relationships with New Measures

and Propensity Score Analysis, 52 Demography 83, 89

(2015), https://link.springer.com/article/10.1007/s13524014-0359-9 (assessing U.S. National Survey of Family

Growth 2015 data and finding fewer unwanted births

received early prenatal care, as compared to wanted

births).

15

The imperative of abortion access to maternal health

takes on added urgency where maternal mortality is

concerned. Unintended pregnancy carries an increased

risk of maternal death. Amirhossein Moaddab et al.,

Health Care Disparity and Pregnancy-Related Mortality

in the United States, 2005–2014, 131 Ob. & Gyn. 707,

709–10 (2018), https://journals.lww.com/greenjournal/

Fulltext/2018/04000/Health_Care_Disparity _and_

Pregnancy_Related.15.aspx?sessionEnd=true. This risk

is compounded for women of color: pregnancy-related

mortality rates for black women are over three times

higher than for white women; rates for Native American

and Alaska Native women are over two times higher

compared to rates for white women. Samantha Artiga et

al., Racial Disparities in Maternal and Infant Health: An

Overview, K aiser Family Foundation (2020), https://www.

kff.org/report-section/racial-disparities-in-maternal-andinfant-health-an-overview-issue-brief/.

Restrictive abortion policies are likewise linked

to maternal death. States whose composite abortion

restriction scores (an 8 -factor test developed by

researchers) were the highest also showed a seven

percent increase in total maternal mortality. Dovile

Vilda et al., State Abortion Policies and Maternal

Death in the United States, 2015–2018, A m . J. P ub .

H ealth e1, e5 (2021), https://ajph.aphapublications.

org/doi /abs/10.2105/AJPH.2021.306396 (examining

maternal mortality in context of current abortion

regulations). Put simply, women living in states with

the most restrictive abortion policies—and thus the

least abortion access—were found to be more likely to

die while pregnant or shortly thereafter than women

living in states with less restrictive abortion policies,

16

regardless of state-to-state differences in poverty, race/

ethnicity, and education. Id.

II. Children Of Women Who Experience Unintended

Pregnancies Face Greater Risks To Life And Health,

Including Pre-Term Birth, Low Birthweight, And

Impaired Child Development And Well-Being

Unintended pregnancies resulting in a live birth entail

higher risks to children’s life and health than planned

pregnancies, underscoring the individual and public health

importance of planned pregnancy and birth. These risks

include pre-term births, low birthweight, and impaired

development and well-being.

A.

Unintended Pregnancy is More Likely to

Result in Pre-Term Birth, Low Birthweight,

and Impaired Development

Unintended, and especially unwanted, pregnancy is

strongly associated with preterm birth and low birthweight,

linked outcomes7 that together are leading causes of child

health problems and infant mortality. See Prakesh S.

Shah et al., Intention to Become Pregnant and Low Birth

Weight and Preterm Birth: A Systematic Review, 15

M aternal & Child Health J. 205, 209 (2011), https://

pubmed.ncbi.nlm.nih.gov/20012348/ (finding significantly

greater odds of prematurity associated with unintended

7. The highest contributing factor for low birthweight is

preterm birth. Committee on Understanding Premature Birth &

A ssuring Healthy Outcomes, Preterm Birth: Causes, Consequences,

and Prevention 120–21 (Richard E. Behrman & Adrienne Stith

Butler eds., 2007).

17

pregnancies); Institute of Medicine, Preventing Low

Birthweight (1985), https://www.ncbi.nlm.nih.gov/books/

NBK214468/ (finding most infant deaths a consequence

of low birthweight). Regardless of age, race, education,

and income, unwanted pregnancy is significantly more

likely to result in pre-term birth and low birthweight.

Kost & Lindberg, supra, at 100–01; Jennifer A. Hall

et al., Pregnancy Intention and Pregnancy Outcome:

Systematic Review and Meta-Analysis, 21 M aternal &

Child Health J. 670, 678 (2017), https://link.springer.com/

article/10.1007/s10995-016-2237-0.

Preterm birth and low birthweight can cause lifelong

health and developmental challenges. Babies born too

early (especially before thirty-two weeks) have higher

rates of death, chronic illness, and developmental disability

than their later-born counterparts, and are more likely

to experience breathing problems, chronic lung disease,

cardiovascular disorders, feeding difficulties, intestinal

injury, cerebral palsy, intellectual and developmental

disabilities, vision problems, hearing problems, and

a compromised immune system. See CDC, Preterm

Birth (2020), http://www.cdc.gov/reproductivehealth/

maternalinfanthealth/pretermbirth.htm; M a rch of

Dimes, Long-Term Health Effects of Premature Birth

(2019), https://www.marchofdimes.org/complications/

long-term-health-effects-of-premature-birth.aspx; see

generally C ommittee on Understanding P remature

Birth, supra n.7, at ch. 10. Low birthweight increases

children’s risk for neurodevelopmental issues and

congenital anomalies and elevates lifelong health risks.

See generally Institute of Medicine, Preventing Low

Birthweight, supra. Inadequate prenatal care, also

linked to unintended pregnancy, increases these risks.

18

Hall et al., supra, at 700. Moreover, children born from

unplanned pregnancies—either mistimed or unwanted—

are more likely to exhibit higher levels of fearfulness,

less opportunity for skill development, and lower levels

of positive affect before two years of age. See Institute

of M edicine , The Best Intentions, supra, at 72–74;

Nazli Baydar, Consequences for Children of Their Birth

Planning Status, 27 Family P lanning P ersp. 228–45

(1995), https://www.jstor.org/stable/2136174.

Births from unwanted pregnancies also negatively

impact the development of earlier-born children. From

six months to four-and-a-half years after their mothers

sought but were unable to obtain abortions, earlier-born

children of women denied abortions had lower mean

child development scores than children of women who

received a wanted abortion. See Diana Greene Foster

et al., Effects of Carrying an Unwanted Pregnancy to

Term on Women’s Existing Children, 205 J. Pediatrics

183, 185 (2019), https://www.jpeds.com/action/showPdf?p

ii=S0022-3476%2818%2931297-6.

B. C h i ld r e n of Wome n W ho Ex p e r ie nc e

Unintended Pregnancies Are More Likely

to Suffer Adverse Child Experiences With

Lifelong Consequences

Children born of unintended pregnancies, and their

siblings, are more likely to be exposed to adverse child

experiences (“ACEs”), i.e. “potentially traumatic events

that occur in childhood (0–17 years).” CDC, Preventing

Adverse Childhood Experiences (2021), https://www.

cdc.gov/violenceprevention/aces/fastfact.html. ACEs

range from a child’s experience of parental separation

19

to violence, abuse, neglect, 8 and other traumas. See

Data Resource Ctr. for Child & A dolescent Health,

2018–2019 National Survey of Children’s Health (2021)

(data query: Indicator 6.13, Has this Child Experienced

One or More Adverse Childhood Experiences from

the List of 9 ACEs?), https://www.childhealthdata.org/

browse/survey/results?q=4783&r=1&g=606. 9 ACEs

cause toxic stress with potentially serious physical and

mental health consequences that accompany children into

8. A child from a family with two unplanned births is 2.8 times

more likely to have been abused than is a child from a family with no

unplanned births; one from a family with three unplanned births is 4.6

times more likely to have been abused. Susan J. Zuravin, Unplanned

Childbearing and Family Size: Their Relationship to Child Neglect

and Abuse, 23 Family Planning Persp. 155, 159 (1991), https://www.

jstor.org/stable/2135738; see also Institute of Medicine, The Best

Intentions, supra; see also Baydar, supra, at 232; Kai Guterman,

Unintended Pregnancy as a Predictor of Child Maltreatment, 48

Child A buse & Neglect 160, 167 (2015), https://www.sciencedirect.

com/science/article/abs/pii/S0145213415001945?casa_token=vb-9lm

5FPJ8AAAAA:ncCXeNO6WTPPsQbSwKBBYcDkOVHKkE34H1I

5dcUI4f9-26GQIpeb0C3nKBSE5TTCvmtJybfH (finding unintended

pregnancy associated with psychological aggression and neglect, as

well as significantly less positive relationships between mothers and

their preschool children).

9. The ACEs recognized in the foundational survey are: (1) it

has “somewhat often” or “very often” been very hard to cover basics

(like food or housing) on the family’s income; (2) a parent or guardian

was divorced or separated; (3) a parent or guardian died; (4) a parent

or guardian served time in jail; (5) the child saw or heard parents or

adults slap, hit, kick, or punch one another in the home; (6) the child

was a victim of violence or witnessed neighborhood violence; (7) the

child lived with someone who was mentally ill, suicidal, or severely

depressed; (8) the child lived with someone who had a problem with

alcohol or drugs; (9) the child was treated or judged unfairly due to

race/ethnicity.

20

adulthood. CDC, Adverse Childhood Experiences (2020),

https://www.cdc.gov/violenceprevention/aces/index.html

(ACEs “have a tremendous impact on future violence

victimization and perpetration, and lifelong health and

opportunity”).

1.

Unintended Pregnancy Resulting in

Birth is Associated with Violence Against

Women and Lifelong Consequences for

Children

Unintended pregnancy carries higher risks of

domestic violence. David M. Fergusson et al., Factors

Associated with Reports of Wife Assault in New Zealand, 48

J. Marriage & Fam. 407, 411–12 (1986), https://www.jstor.org/

stable/352408 (finding, within six years following birth,

women whose pregnancies were unintended experienced

a 13.4 percent rate of physical violence, nearly three times

the 5.4 percent rate for women whose pregnancies were

planned); Julie A. Gazmararian et al., The Relationship

Between Pregnancy Intendedness and Physical Violence

in Mothers of Newborns, 85 Ob. & Gyn. 1031, 1033–35

(1995), https://pubmed.ncbi.nlm.nih.gov/7770250/ (finding

higher rates of physical violence against women with

unintended pregnancies, based on four-state study of data

gathered from women three to six months after delivery).

Between 5.6 and 10.7 percent of women whose pregnancies

were unintended reported physical abuse; the rate for

women who had planned their pregnancies was between

3.8 and 6.9 percent. Gazmararian et al., supra.

Domestic violence is toxic and traumatizing for children.

CDC, Preventing Adverse Childhood Experiences, supra.

Children of women who experience domestic violence

21

have increased risks of emotional, physical, and sexual

abuse, of developing emotional and behavioral problems,

and of increased exposure to other adversities. See

generally, Stephanie Holt et al., The Impact Of Exposure

To Domestic Violence On Children And Young People:

A Review Of The Literature, 32 Child A buse & Neglect

797 (2008), https://doi.org/10.1016/j.chiabu.2008.02.004.10

2.

Unintended Pregnancy and Birth is

A s so ciat e d w ith Great er Pa rent a l

Mental Health Challenges and Lifelong

Consequences for Children

The mental health of parents is critical to the health

of their children. Compared to women with planned

pregnancies, mothers experiencing unintended pregnancy

and birth were more likely to report postpartum

depression, as well as poorer mental health later in life.

Cheng et al., supra, at 196–97; Institute of Medicine,

The Best Intentions, supra, at 75; Pamela Herd et al.,

The Implications of Unintended Pregnancies for Mental

Health in Later Life, 106 A m. J. Pub. Health 421, 422

(2016), https://w w w.ncbi.nlm.nih.gov/pmc/articles/

PMC4815713/pdf/AJPH.2015.302973.pdf; Jessica Houston

Su, Pregnancy Intentions and Parents’ Psychological

Well-Being, 74 J. M arriage & Fam. 1182, 1190–93 (2012),

https://onlinelibrary.wiley.com/doi/abs/10.1111/j.17413737.2012.01006.x. Maternal depression limits the ability

to nurture and is associated with long-term socialemotional, mental health, and behavioral problems in

children. Sarah K.G. Jensen & Theresa S. Betancourt,

10. See also Guterman, supra n.8, at 167 (finding association

between unintended pregnancies and fathers’ physical aggression).

22

Recognizing the Complexity of Psychosocial Factors

Associated With Children’s Development—The Case of

Maternal Depression, 4 JAMA Network Open 1 (2021),

doi:10.1001/jamanetworkopen.2021.22310. A childhood

marked by a parent’s mental health struggles is linked

to increased risk of mental illness, behavioral difficulties,

and substance use in adulthood. CDC, Preventing Adverse

Childhood Experiences, supra.

Overall, denying women the ability to plan their

pregnancies negatively impacts their children, who

are more likely to live in poverty and have a parent in

emotional distress as result of the denial of the abortion.

See Foster et al., Effects of Carrying an Unwanted

Pregnancy to Term, supra; Foster et al., Comparison of

Health, Development, supra, at 1054.

3.

Unintended Pregnancy and Birth is

Associated with Elevated Rates of Death,

Divorce, or Separation and Lifelong

Consequences for Children

The loss of a parent or guardian through death,

divorce, or separation is an ACE with potentially lifelong

negative consequences for children. As noted supra,

women with unintended pregnancies are at a higher

risk for maternal death than women able to plan their

pregnancies and birth. Moaddab et al., supra, at 709–10.

Additionally, marriages that follow an unintended

pregnancy have a higher chance of failure, regardless of

whether the marriage is a first, second, or subsequent

marriage. Institute of Medicine, The Best Intentions,

supra, at 74.

23

III. Mississippi And Thirteen Other States With

Extensive Abortion Restrictions Invest The Least

In The Health And Well-Being Of Women And

Children And Show The Worst Health Outcomes

For Mothers, Infants And Children

A state-by-state11 review of abortion restrictions,

objective and widely-accepted measures of women’s and

children’s health outcomes, and state investments in

maternal and child health underscores a central paradox:

among the fifty states and the District of Columbia, (1)

Mississippi and other states with the most restrictive

abortion policies invest the least in the well-being of

women, children, and families; and (2) mothers, infants,

and children in these high-restriction, low-investment

states have the worst health outcomes. See App. Table

1 (ranking states from one to fifty-one on five distinct

maternal and child health indicators, where ranking first

for a particular measure indicates the state’s outcomes

for that measure are better than all other states); Table 2

(indicating the extent of each state’s policies related to nine

basic investments in maternal and child health programs);

Table 3 (ranking fourteen states imposing seven or more

abortion restrictions, including a gestational ban, in terms

of their performance on five maternal and child health

outcomes in Table 1); and Table 4 (ranking fourteen states

imposing seven or more abortion restrictions, including

a gestational ban, on their policies related to nine basic

investments in maternal and child health programs).

11. For purposes of this review, the District of Columbia was

treated as a state, resulting in data and findings pertaining to 51

“states.”

24

Further, the unintended pregnancy rate is highest

among the states with the most restrictive abortion

policies. Eleven out of the fourteen high-restriction states

whose results appear on Tables 3 and 4 report unintended

pregnancy rates at or above the U.S. average. See App.

Tables 3, 4; see generally Kathryn Kost, Unintended

Pregnancy Rates at the State Level: Estimates for

2010 and Trends Since 2002, Guttmacher Institute

(2015), https://www.guttmacher.org/sites/default/files/

report_pdf/stateup10.pdf.12 Among all states tracking

and reporting relevant data, Mississippi had the lowest

rate of planned pregnancy (thirty-five percent). Kost,

Unintended Pregnancy Rates, supra, at 7, 8, Table 1;

see also United Health Foundation, America’s Health

Rankings: Unintended Pregnancy (2021), https://www.

americashealthrankings.org/explore/health-of-womenand-children/measure/unintended_pregnancy/state/U.S

(ranking Mississippi, based on 2018 CDC data, as the least

healthy state in terms of the percentage of women with a

recent live birth who experienced unwanted or mistimed

pregnancies).

Taken together, the evidence overwhelmingly shows

that compelling women to carry unintended—and

especially unwanted—pregnancies to term is detrimental

to the health of women, children, and families. The evidence

also shows that Mississippi and other states with the

Nation’s most restrictive abortion policies simultaneously

fail to invest in the very women, children, and families

most heavily affected by unintended pregnancies.

12. Not all states report unintended pregnancies. Among the

fourteen high-restriction states, two do not report figures and one

has a rate below the national average. Id.

25

A.

Certain States, Including Mississippi, Lead the

Nation in the Number of Abortion Restrictions

According to the Kaiser Family Foundation and the

Guttmacher Institute, among the fifty states and the

District of Columbia, Mississippi and thirteen other states

impose the most restrictive abortion policies as measured

by: (1) counseling requirements; (2) waiting periods;

(3) ultrasound requirements; (4) parental notification

and consent requirements; (5) gestational limits; (6)

restrictions on insurance coverage for abortion; and (7)

regulation of facilities and clinicians providing abortions.13

See App. Tables 3, 4. Although many of these restrictions

are common across states, only fourteen states have

simultaneously pursued all seven categories of limitations.

In addition to Mississippi, they are: Alabama, Arkansas,

Indiana, Kansas, Kentucky, Louisiana, Nebraska, North

Dakota, Ohio, Oklahoma, South Carolina, South Dakota,

and Texas. Id.

The seven restrictions in Mississippi and thirteen other

high-restriction states create obstacles to care that simply

do not exist for other medical procedures that, like abortion,

are safe and common. Cf. Whole Woman’s Health, 136 S. Ct.

at 2315 (noting mortality rate for colonoscopies ten times

higher than that for abortion, liposuction twenty-eight times

higher); June Medical Services, LLC v. Russo, 140 S. Ct.

2103, 2124 (2020). These restrictions reflect an ideologicallydriven strategy to make abortion access practically and

13. Restrictiveness rankings are based on Kaiser Family

Foundation data focused on state-level policies. K aiser Family

Foundation, State Health Facts, Women’s Health: Women’s Health

Indicators: Abortion Statistics and Policies (2021), https://www.kff.

org/state-category/womens-health/abortion-statistics-and-policies/.

26

financially burdensome, if not impossible, regardless of the

detrimental impact to public health. For example, gestational

age bans, like Mississippi’s, effectively preclude abortion

entirely within a state’s borders, while mandatory waiting

periods trigger costly and time-consuming travel obligations,

restrictions on health care providers and practice settings

limit available providers, and restrictions on insurance

coverage—including for Medicaid beneficiaries—increase

out-of-pocket costs, often prohibitively. Ideologically-driven

and medically unsupported efforts to hinder women’s

access to comprehensive reproductive healthcare also

increasingly include restrictions on the use of medication

abortions—accomplished through the FDA-approved use

of the drugs mifepristone and misoprostol—as they become

more common. Rachel K. Jones & Jenna Jerman, Abortion

Incidence and Service Availability in the United States,

2017, 49 Persp. on Sexual & Reprod. Health 17, 18 (2017),

https://www.guttmacher.org/report/abortion-incidenceservice-availability-us-2017.14

B. Measures of Health and Health Investment in

Mississippi and Other High-Restriction States

Reveal Deeply Deficient Safety Net Investments

and Poor Health Outcomes Among Women,

Children, and Families

Objective measures of public health and health

investment reveal that Mississippi and its companion

high-restriction states stand at the bottom of all states

in terms of basic investment in maternal and child health

programs and services, underscoring the disregard for

public health inherent in its abortion ban.

14. Data related to restrictions on medication abortions is not

currently adequately comprehensive for inclusion in the analysis

undertaken herein.

27

Population health and health investment measures

utilized in public health policy and practice fall into

two categories: public health indicators and safetynet measures. These measures are considered leading

methods for assessing health risks among women,

mothers, infants, and children, as well as the strength of

social and health investment. See generally, Russell S.

Kirby & Sarah Verbiest, Kotch’s Maternal and Child

Health: Programs , Problems and Policy in Public

Health (4th ed. 2021).

Widely accepted public health indicators regarding

pregnancy, childbirth, deaths in infancy, and the wellbeing of children include: early entry into prenatal care,

(care in the first trimester of pregnancy); infant mortality

(infant death occurring before the first birthday); low

birthweight (weight at birth of less than 5.5 pounds);

poverty rate among children under five (children who live in

families with incomes below FPL); and adverse childhood

experiences, (defined in supra section II(B)). CDC, Entry

into Prenatal Care—United States, 1989–1997 (2000) at

393–98, https://www.cdc.gov/mmwr/preview/mmwrhtml/

mm4918a1.htm; CDC, Infant Mortality (2021), https://

www.cdc.gov/reproductivehealth/maternalinfanthealth/

infantmortality.htm; Natl . Cancer I nstitute , Natl .

I nstitutes of H ealth , Dictionary of Cancer Terms

(2021), https://www.cancer.gov/publications/dictionaries/

cancer-terms/def/low-birth-weight; U.S. Dept. of Health

& Human Servs., Annual Update of the HHS Poverty

Guidelines, supra n.5.

Health safety-net measures consist of policies that

extend health, health care, nutritional, and basic support

services to the most vulnerable women, children, and

28

families. Noteworthy policies promote access to preconception and early and comprehensive perinatal health

care, as well as offer nutritional support during pregnancy,

infancy, and early childhood, and financial support for

families with infants and young children. See generally

Select Panel for the P romotion of Child H ealth,

Better Health for Our Children: A National Strategy,

Report to the United States Congress and the Secretary of

Health & Human Servs. (1981), https://catalog.hathitrust.

org/Record/000200804 (discussing health investments

in children); see also CDC, Health, United States 6–7,

11–13 (2019), https://www.cdc.gov/nchs/hus/index.htm

(discussing national and state-level women’s health and

well-being measures before and during pregnancy, and

measures for infants and children).

Government safety net investment is commonly

analyzed with reference to state Medicaid coverage

policies for children and working-age adults;15 financial

assistance during pregnancy, infancy and childhood under

states’ Temporary Assistance for Needy Families (TANF)

15. Medicaid and its supplemental companion, the Children’s

Health Insurance Program (“CHIP”), codified respectively at

42 U.S.C. §§ 1396a et seq. and 1397 et seq., insured 81.7 million

adults and children as of March 2021. See Bradley Corallo & Robin

Rudowitz, Analysis of Recent National Trends in Medicaid and

CHIP Enrollment, K aiser Family Foundation (2021), https://www.

kff.org/coronavirus-covid-19/issue-brief/analysis-of-recent-nationaltrends-in-medicaid-and-chip-enrollment/; see also Julia Paradise,

Barbara Lyons & Diane Rowland, Medicaid at 50, K aiser Family

Foundation (2015), https://www.kff.org/report-section/medicaidat-50-low-income-pregnant-women-children-and-families-andchildless-adults/ (Medicaid insures forty-six percent of all U.S.

births and covers seventy-seven percent of children in poverty under

eighteen).

29

programs;16 and assistance furnished to women, infants

and young children under the Special Supplemental

Nutrition Program for Women, Infants, and Children

(WIC).17 These basic supports take on special importance

for women who experience unintended pregnancy

who, as noted supra, are collectively more likely to be

young, poor, financially and socially disadvantaged, and

disproportionately women and children of color who labor

under added historical burdens of racial segregation,

discrimination, and exclusion.

1.

Maternal and Child Health Indicators

in Mississippi and the Other HighRestriction States Reveal Poorer Public

Health Outcomes Compared to States with

Greater Abortion Access

The fourteen high-restriction states show consistently

poor performance on maternal and child health indicators.

Among the fourteen states with the highest number of

16. Federal TANF grants to states extend basic financial

assistance and supportive services to families with children. 42

U.S.C. § 601 et seq. State TANF spending and the level of assistance

families receive is discretionary. See, e.g., Center on Budget &

Policy Priorities, Policy Basics: Temporary Assistance for Needy

Families (2021), https://www.cbpp.org/research/family-incomesupport/temporary-assistance-for-needy-families.

17. Federal WIC grants to states cover supplemental foods,

nutrition education, and health care referrals for low-income

pregnant, breast-feeding, and postpartum women, as well as atrisk infants and children. WIC serves fifty-three percent of all

infants born in the U.S. Food and Nutrition Service, U.S. Dept. of

Agriculture (hereinafter “FNS”),WIC at a Glance (2013), https://

www.fns.usda.gov/wic/about-wic-glance.

30

abortion restrictions, nine (64.3 percent) rank in the lower

half of states in terms of early entry into prenatal care;

ten (71.4 percent) rank in the lower half of all states in

terms of infant mortality; and eight (57.1 percent) rank in

the lower half of states in terms of low birthweight. With

respect to young children in poverty, ten of the fourteen

states (71.4 percent) show childhood poverty rates higher

than twenty-five other states, two—Louisiana and

Mississippi—rank 50th and 51st respectively. Considering

ACEs, eleven of fourteen states rank in the lower half of

all states (78.6 percent) in terms of the number of at-risk

children. See App. Table 3.

Even as Mississippi seeks to ban abortion previability, its residents experience some of the nation’s most

elevated reproductive health risks. Further, Mississippi’s

health care system is grievously unprepared to deal with

the cascading effects of unintended pregnancy. Mississippi

ranked last in the Commonwealth Fund’s 2020 Composite

Score for Health System Performance in the United

States, including ranking as worst performing for, among

other measures: infant mortality; mortality amenable to

health care or preventable deaths; and children without

age-appropriate medical and dental preventive care visits

in the past year. Commonwealth Fund, 2020 Scorecard

on State Health System Performance, Mississippi (2020),

https://2020scorecard.commonwealthfund.org/files/

Mississippi.pdf.

31

2.

Safety Net Investment is Inadequate in

Mississippi and the Other High-Restriction

States and Lower than that in States with

Greater Abortion Access

States w ith the g reatest number of abor tion

restrictions—including a gestational ban on abortion like

Mississippi’s— show the lowest overall investment rates

in women, children, and families, even when it comes to

medical care itself. This lack of investment puts the lie to

abortion bans justified by a claimed interest in the wellbeing of women, children, and families.

The most restrictive abortion states include half of

the twelve states that have not adopted the Medicaid

program expansion authorized in the Patient Protection

and Affordable Care Act (“ACA”), Pub. L. 111–48 (Mar.

23, 2010). Medicaid participating states must provide

coverage, from the point at which pregnancy is established

through the last day of the month in which the 60 th

postpartum day occurs, to all pregnant women whose

household income does not exceed 138 percent of FPL

($30,305 for a family of 3 in the 48 contiguous United

States and the District of Columbia in 2021). See 42 U.S.C.

§§ 1396a(a)(10)(A)(i)(IV), (l)(1)–(2). States may, at their

option, extend Medicaid and CHIP to additional pregnant/

postpartum women and children deemed eligible based

on their household incomes. See 42 U.S.C. § 1396a(a)

(10)(A)(ii)(IX). States may also expand eligibility for a

narrow benefit package of family planning and “family

planning related” services. See 42 U.S.C. § 1396a(a)(10)

(A)(ii)(XXI), (B)(ii). This option offers limited coverage,

but is significantly less protective of overall health than

full Medicaid coverage in states that have expanded

32

Medicaid under the ACA, per 42 U.S.C. § 1396a(a)(10)(A)(i)

(VIII). For poor women of childbearing age—historically

excluded from Medicaid unless pregnant, disabled, or

raising children in deep poverty—the ACA expansion

represents a vital pathway to comprehensive coverage

of health care needs prior to, throughout, and well after

pregnancy. K aiser Family Foundation, Medicaid’s Role

for Women 2–5 (2019), https://files.kff.org/attachment/

Fact-Sheet-Medicaids-Role-for-Women. Mississippi has

not expanded Medicaid, thereby choosing to forgo these

crucial health supports.

In Mississippi and the thirteen other high-restriction

states, women of reproductive age—if not already

pregnant, disabled or a parent—may at best qualify for

limited family planning benefits. Within the six nonexpansion states, four (including Mississippi) set the

Medicaid eligibility rate for parents at less than forty

percent FPL. Three of these four states (including

Mississippi) limit Medicaid eligibility for parents to

twenty-five percent FPL or less, meaning that parents

do not qualify for Medicaid in these states if their annual

income exceeds—at most— $5,490 for a family of three

in 2021.

Medicaid in these high-restriction states is of limited

reach even for pregnant women. Across all states, the

median income eligibility level for pregnant women is 200

percent FPL; among the fourteen high-restriction states,

six—including Mississippi—fall below the median. Even

among highly restrictive abortion states with limited

investment policies, Mississippi is routinely at or near

the bottom in terms of Medicaid availability for young,

impoverished women, who, as noted supra, are most likely

to experience unintended pregnancy.

33

Moreover, the fourteen high-restriction states

similarly restrict financial and nutrition assistance to

women, children, and families. The national median

monthly TANF payment for a family of three is $492. See

App. Table 4. Among the fourteen high-restriction states,

twelve, including Mississippi, fall below this standard. Id.

Nationally, 21.7 percent of poor infants receive TANF

benefits. Among the most restrictive states, all but Ohio

fall below this national average; Mississippi holds the

penultimate rank, providing TANF assistance only to 8.6

percent of infants living in the state’s poorest households.

Id.

Of the 6.87 million served by WIC each month in FY

2018, children represented approximately three-quarters

of all participants. FNS, WIC Frequently Asked Questions

(FAQs) (2019), https://www.fns.usda.gov/wic/frequentlyasked-questions. Infants consistently have the highest

participation rate. FNS, WIC Eligibility and Coverage

Rates (2018), https://www.fns.usda.gov/wic/eligibilityand-coverage-rates-2018. WIC-eligible women and

children must be high risk, either due to “medically-based

risks” (e.g. anemia, maternal age, history of pregnancy

complications, or poor pregnancy outcomes) or “diet-based

risks” linked to inadequate dietary patterns. FNS, WIC

Frequently Asked Questions (FAQs), supra. Financial

eligibility is set at 185 percent of FPL. Id. States have

considerable flexibility to simplify WIC enrollment and

can liberalize the financial eligibility methodologies they

use to help boost participation. Committee on Natl. Stat.,

Natl. Research Council, Estimating Eligibility and

Participation for the WIC Program: Phase I Report, 15–18

(2001), https://www.ncbi.nlm.nih.gov/books/NBK223572/.

Because families can establish WIC eligibility by showing

34

Medicaid participation, Medicaid eligibility factors also

influence WIC participation. Steven Carlson et al., WIC

Participation and Costs are Stable, Center on Budget

& Policy Priorities (2017), at 12, https://www.cbpp.org/

research/food-assistance/wic-participation-and-costsare-stable.

The national average WIC participation standard for

eligible women stands at sixty-nine percent. Among the

fourteen states that most restrict abortion access, eight

fall below this standard. See App. Table 4.

The high-restriction, low-investment states’ purported

concern for the well-being of women and children is belied

by the degree to which they have rejected investment in

the very programs designed to protect women, children,

and families. In Mississippi, the substantial harms to

public health flowing from the state’s violation of women’s

constitutional right to abortion access are compounded by

inadequate health care and social welfare systems that

fail women, children and families.

CONCLUSION

Objective evidence overwhelmingly points to abortion

access as a necessary tool in promoting health and in

mitigating health threats to women and families inherent

in unintended, and particularly unwanted, pregnancies.

Women depend on abortion access as an essential health

safeguard; evidence shows women seeking abortion do so

in great part for their health and well-being and that of

their families.

Mississippi and thirteen other states that have

pursued the most far-reaching and intrusive abortion

35

policies also demonstrate a consistent and marked failure

to invest in maternal and child health, a reality that

stands in stark contrast to any claim that a pre-viability

abortion ban demonstrates respect for life. A review of

key population health indicators underscores the fact

that mothers and children in these states experience the

worst health outcomes and must face pregnancy, birth,

and childhood with the greatest deficit of health, health

care, and social supports.

For the foregoing reasons, Amici respectfully urge

the Court to affirm the decision below.

September 20, 2021

Respectfully submitted,

Edward T. Waters

Counsel of Record

Phillip A. Escoriaza

Rosie Dawn Griffin

Feldesman Tucker Leifer

Fidell LLP

1129 20th Street, N.W.,

Fourth Floor

Washington, D.C. 20036

(202) 466-8960

ewaters@ftlf.com

Counsel for Amici Curiae

APPENDIX

1a

LISTINGAppendix

OF INDIVIDUAL

AMICI CURIAE WITH TABLES

Deans and Associate Deans

1.

Nerys Benfield, MD, MPH, Senior Associate Dean

of Diversity and Inclusion, Director, Division of Family Planning and the Fellowship in Family Planning,

Director, Social Obstetrics and Gynecology Program,

Associate Professor, Department of Obstetrics & Gynecology and Women’s Health, Albert Einstein College of Medicine – Montefiore Medical Center

2.

Harris A. Berman, MD, FACP, Dean Emeritus, Tufts

University School of Medicine

3.

Sandy Dorcelus, DO, FACOG, Assistant Dean of Diversity and Inclusion, NYU Long Island School of

Medicine, Assistant Clinical Professor, Department

of Obstetrics and Gynecology, NYU Langone Health

Long Island

4.

Ayman El-Mohandes, MBBCh, MD, MPH, Dean,

CUNY Graduate School of Public Health & Health

Policy

5.

Jill C. Engle, JD, Associate Dean for Academic Affairs, Penn State Law, The Pennsylvania State University

6.

Susan L. Ettner, PhD, Associate Dean, U.C.L.A.

Graduate Division, Professor, David Geffen School of

Medicine, Division of General Internal Medicine and

Health Services Research, University of California,

Los Angeles

2a

Appendix

7.

Linda P. Fried, MD, MPH, Dean and DeLamar

Professor of Public Health, Senior Vice President,

Columbia University Medical Center, Professor of

Epidemiology and Medicine, Columbia University

Mailman School of Public Health

8.

Sandro Galea, MD, DrPH, Dean, Robert A. Knox

Professor, School of Public Health, Boston University

9.

Anne Garrison, MD, Interim Associate Dean for

Student Affairs, Assistant Dean for Professional Development, Associate Director, Division of General

OBGYN, Assistant Professor of OBGYN, University

of Massachusetts Medical School, UMass Memorial

Medical Center

10. S. Marie Harvey, DrPH, MPH, OSU Distinguished

Professor of Public Health, Associate Dean for Research, College of Public Health and Human Sciences, Oregon State University

11. Cheryl Healton, DrPH, Dean, NYU School of Global

Public Health

12. Jane Hyatt Thorpe, JD, Sr. Associate Dean for Academic, Student and Faculty Affairs, Professor of

Health Policy and Management, Milken Institute

School of Public Health, The George Washington

University

13. Adnan Hyder, MD, MPH, PhD, Senior Associate

Dean for Research, Professor of Global Health,

3a

Appendix

Milken Institute School of Public Health, The George

Washington University

14. Michael J. Klag, MD, MPH, Dean Emeritus, Second

Century Distinguished Professor, Johns Hopkins

Bloomberg School of Public Health

15. Thomas A. LaVeist, PhD, Dean and Professor, Tulane University School of Public Health and Tropical

Medicine

16. Aviva Lee-Parritz, MD, Chief, Department of Obstetrics and Gynecology, Boston Medical Center,

Chair and Associate Professor of Obstetrics and Gynecology, Assistant Dean of Faculty Practice, Boston

University School of Medicine

17. Michael C. Lu, MD, MS, MPH, Dean, School of Public Health, University of California, Berkley

18. Ellen J. MacKenzie, PhD, Dean, Bloomberg Distinguished Professor, Johns Hopkins Bloomberg School

of Public Health

19. Leila J. Rupp, PhD, Interim Anne and Michael

Towbes Graduate Dean, Distinguished Professor

of Feminist Studies, University of California, Santa

Barbara

20. Mark A. Schuster, MD, PhD, Founding Dean and

CEO; Professor, Health Systems Science, Kaiser

Permanente Bernard J. Tyson School of Medicine

4a

Appendix

21. Tetine Sentell, PhD, Interim Dean, Professor of Public Health, Thompson School of Social Work and Public Health, University of Hawai’i at Mānoa

22. Alfred Sommer, MD, Dean Emeritus, Professor,

Johns Hopkins Bloomberg School of Public Health

23. Sten H. Vermund, MD, PhD, Dean and Anna M.R.

Lauder Professor of Public Health; Professor of Pediatrics, Yale School of Medicine, Yale University

24. Sara E. Wilensky, JD, PhD, Assistant Dean for Undergraduate Education, Director, Undergraduate

Program in Public Health, Special Services Faculty for Undergraduate Education, Milken Institute

School of Public Health, The George Washington

University

25. Heather M. Young, PhD, RN, FAAN, Professor and

Dean Emerita, Betty Irene Moore School of Nursing, University of California, Davis

Chairs

1.

Jeffrey S. Akman, MD, Walter A. Bloedorn Professor of Administrative Medicine and Interim Chair,

Department of Psychiatry and Behavioral Sciences,

School of Medicine and Health Sciences, The George

Washington University

2.

Amy (Meg) Autry, MD, Professor, Vice Chair of GME

and CME, Department of Obstetrics, Gynecology,

and Reproductive Sciences, University of California,

San Francisco

5a

Appendix

3.

Sarah Baird, PhD, Professor and Vice Chair, Department of Global Health, Milken Institute School of

Public Health, The George Washington University

4.

Carrie N. Baker, JD, PhD, Sylvia Dlugasch Bauman

Chair of American Studies, Professor, Program for

the Study of Women and Gender, Smith College

5.

Robert L. Barbieri, MD, Chief of Obstetrics, Brigham

and Women’s Hospital

6.

Julia Zoe Beckerman, JD, MPH, Teaching Associate Professor and Vice Chair, Department of Health

Policy and Management, Milken Institute School of

Public Health, The George Washington University

7.

Janice Bowie, PhD, MPH, Bloomberg Centennial

Professor, Chair, Schoolwide DrPH Program, Department of Health, Behavior and Society, Johns

Hopkins Bloomberg School of Public Health

8.

Alison Brysk, PhD, Chair, Global Studies Department, Mellichamp Professor of Global Governance,

University of California, Santa Barbara

9.

Serdar Bulun, MD, John J. Sciarra Professor, Chair,

Department of Obstetrics and Gynecology, Feinberg

School of Medicine at Northwestern University

10. Jillian Catalanotti, MD, MPH, FACP, Associate Professor of Medicine & of Health Policy and Management, Vice Chair for Academic Affairs, Department

of Medicine, Director, Division of General Internal

Medicine, The George Washington University

6a

Appendix

11. Aaron B. Caughey, MD, PhD, Professor and Chair,

Department of Obstetrics & Gynecology, Associate

Dean for Women’s Health Research & Policy, Oregon

Health & Science University

12. David D. Celentano, ScD, MHS, Dr. Charles Armstrong Chair in Epidemiology, Professor and Chair,

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health

13. Parul Christian, DrPH, MSc, Professor, Director

and Associate Chair, Department of International

Health, Johns Hopkins Bloomberg School of Public

Health

14. Natalia Deeb-Sossa, Interim Chair and Associate

Professor, Chicana/o Studies Department, University of California, Davis

15. Christine Dehlendorf, MD, MAS, Professor, Vice

Chair for Research, Family & Community Medicine,

Director, Person-Centered Reproductive Health

Program, Department of Family & Community Medicine, Obstetrics, Gynecology & Reproductive Sciences, and Epidemiology & Biostatistics, University

of California, San Francisco

16. Eve Espey, MD, MPH, Distinguished Professor and

Chair, Department of OB-GYN, University of New

Mexico

17. Scott Evans, PhD, Founding Chair and Professor,

Department of Biostatistics and Bioinformatics, Di-

7a

Appendix

rector of Biostatistics Center, Milken Institute School

of Public Health, The George Washington University

18. Ethan D. Fried, MD, MACP, Associate Chair for Education, Residency Program Director, Department

of Internal Medicine, Professor of Medicine, Zucker

School of Medicine at Hofstra/Northwell

19. Nancy D. Gaba MD, FACOG, Oscar I. and Mildred

S. Dodek and Joan B. and Oscar I. Dodek, Jr. Professor and Chair, Department of Obstetrics and Gynecology, The George Washington University School of

Medicine and Health Sciences

20. Gelila Goba, MD, MPH, FCOG, Associate Professor

of Obstetrics and Gynecology, University of Illinois

21. Barbara Goff, MD, Chair, Obstetrics and Gynecology,

University of Washington, Surgeon-in-Chief, University of Washington Medical Center

22. Atul Jain, MD, MS, Associate Dean, Mayo Clinic

School of Continuous Professional Development,

Vice-Chair, Division of General Internal Medicine,

Associate Program Director, Mayo Internal Medicine Residency, Assistant Professor of Medicine,

Mayo College of Medicine

23. Hadine Joffe, MD, MSc, Executive Director, Mary

Horrigan Connors Center for Women’s Health and

Gender Biology, Paula A. Johnson Associate Professor of Psychiatry in the Field of Women’s Health,

Harvard Medical School, Vice Chair for Research,

8a

Appendix

Department of Psychiatry Brigham and Women’s

Hospital

24. Leslie M. Kantor, PhD, MPH, Professor and Chair,

Department of Urban-Global Public Health, Director, Urban Public Health Concentration, Director,

Maternal Child Health Certificate, Rutgers School

of Public Health

25. Caitlin Kennedy, MPH, PhD, Associate Professor,

Director, Social and Behavioral Interventions Program, Associate Chair, Department of International

Health, Johns Hopkins Bloomberg School of Public

Health

26. Sally J. Kenney, PhD, Newcomb College Endowed

Chair, Executive Director, Newcomb Institute, Professor of Political Science, Tulane University

27. Susan Lane, MD, FACP, Internal Medicine Residency Program Director, Professor of Medicine, Vice

Chair of Education, Stony Brook Medicine

28. Joseph Loscalzo, MD, PhD, Hersey Professor of the

Theory and Practice of Medicine, Harvard Medical

School, Chairman of the Department of Medicine and

Physician-in-Chief, Brigham and Women’s Hospital

29. Manya Magnus, PhD, MPH, Professor & Interim

Chair, Department of Epidemiology, Milken Institute School of Public Health, The George Washington University

9a

Appendix

30. Lisa A. Martin, PhD, Interim Department Chair,

Health and Human Services, Associate Professor of

Women’s and Gender Studies, Associate Professor of

Health and Human Services, University of Michigan,

Dearborn

31. Karen McDonnell, PhD, Associate Professor and

Vice Chair, Department of Prevention and Community Health, Milken Institute School of Public Health,

The George Washington University

32. Terry McGovern, JD, Professor and Chair, Heilbrunn Department of Population and Family Health,

Mailman School of Public Health, Columbia University

33. Tiffany A. Moore Simas, MD, MPH, MEd, FACOG,

Chair, Department of Obstetrics & Gynecology, Pediatrics, Psychiatry and Population & Quantitative

Health Sciences, University of Massachusetts Medical School/UMass Memorial Health

34. Jack Needleman, PhD, FAAN, Fred W. and Pamela

K. Wasserman Professor and Chair, Department of

Health Policy and Management, Fielding School of

Public Health, University of California, Los Angeles

35. Nawal M. Nour, MD, MPH, Chair, Department of

Obstetrics and Gynecology, Kate Macy Ladd Professorship, Harvard Medical School

36. Laury Oaks, PhD, Professor and Chair, Department

of Feminist Studies, University of California, Santa

Barbara

10a

Appendix

37. Tony Ogburn, MD, Professor and Chair, Department of Obstetrics and Gynecology, UTRGV School

of Medicine

38. Anne R. Pebley, PhD, Distinguished Professor and

Fred H. Bixby Chair, Chair, Bixby Center on Population and Reproductive Health, Fielding School of

Public Health, University of California, Los Angeles

39. Jeffrey F. Peipert, MD, PhD, Clarence E. Ehrlich

Professor and Chair, Indiana University School of

Medicine, Department of Obstetrics & Gynecology

40. Ndola Prata, MD, MSc, Fred H. Bixby Endowed

Chair in Population and Family Planning, Professor,

Maternal and Child Health, Director, Innovations for

Youth, School of Public Health, Director, Center of

Expertise in Women’s Health, Gender and Empowerment, Global Health Institute, University of California, Berkley

41. Eva K. Pressman, MD, Henry A. Thiede Professor

and Chair, Obstetrics and Gynecology, University of

Rochester

42. Gwendolyn P. Quinn, PhD, Livia Wan, MD Endowed

Chair, Vice-Chair of Research, Professor, Departments of OB-GYN, Population Health, Division of

Medical Ethics, New York University, Grossman

School of Medicine

43. Laurel W. Rice, MD, Ben Miller Peckham, MD, PhD,

Chair in Obstetrics and Gynecology, Chair and Pro-

11a

Appendix

fessor, Department of Obstetrics and Gynecology,

University of Wisconsin-Madison School of Medicine

and Public Health

44. Heather Z. Sankey, MD, MEd, FACOG, CPE, Ronald T. Burkman Endowed Chair of Obstetrics and

Gynecology, Baystate Health, Professor and Chair,

University of Massachusetts Medical School-Baystate

45. Becky Slifkin, PhD, Professor and Associate Chair,

Department of Health Policy and Management,

UNC Gillings School of Global Public Health

46. Leslee L. Subak, MD, Katharine Dexter McCormick

and Stanley McCormick Memorial Professor, Chair,

Department of Obstetrics and Gynecology, Professor, by Courtesy, Department of Urology, Stanford

University School of Medicine

47. James M. Tielsch, PhD, MA, Professor and Chair, Department of Global Health, Milken Institute School

of Public Health, The George Washington University

48. Alan G. Wasserman, MD, Eugene Meyer Professor

of Medicine, Chair, Department of Medicine, President, Medical Faculty Associates, The George Washington University

49. Morris Weinberger, PhD, Vergil N. Slee Distinguished Professor of Healthcare Quality Management, Chair, Department of Health Policy and Management, Gillings School of Global Public Health,

University of North Carolina at Chapel Hill

12a

Appendix

50. Nikki B. Zite, MD, MPH, Professor, Vice Chair of

Education and Advocacy, Department of OB/GYN,

University of Tennessee Graduate School of Medicine

Scholars and Public Health Professionals

1.

Alice Abernathy, MD, National Clinician Scholars

Program, Department of Obstetrics & Gynecology,

Perelman School of Medicine, University of Pennsylvania

2.

Jamie R. Abrams, JD, LLM, Professor of Law, University of Louisville Brandeis School of Law

3.

Paula J. Adams Hillard, MD, Professor, Department

of Obstetrics and Gynecology, Stanford University

School of Medicine

4.

Amy E. Alterman, MPH, Teaching Fellow, UCLA

5.

Anna Altshuler, MD, MPH, Obstetrician/Gynecologist, Researcher, Medical Director, Sutter Health,

California Pacific Medical Center, Mission Bernal

Women’s Clinic

6.

Georgina F. Amaral, MD, MSL, Interim Medical Director, OB/GYN, Planned Parenthood Southeast

7.

Jocelyn C. Anderson, PhD, RN, SANE-A, Assistant

Professor, College of Nursing, Penn State University

8.

Katherine Andrinopoulos, PhD, Associate Professor,

Director of Doctoral Program, Department of Inter-

13a

Appendix

national Health and Sustainable Development, Tulane School of Public Health and Tropical Medicine

9.

George J. Annas, Director, Center for Health Law,

Ethics & Human Rights, Boston University School

of Public Health

10. Robert M. Arnold, MD, Distinguished Service Professor of Medicine, Department of Medicine, Chief,

Section of Palliative Care and Medical Ethics, Director, Institute for Doctor-Patient Communication,

University of Pittsburgh School of Medicine

11. Marice Ashe, JD, MPH, Lecturer, Public Health Law,

Berkeley Law, University of California at Berkeley

12. Alev J. Atalay, MD, Instructor of Medicine, Harvard

Medical School; Director of Ambulatory Education,

Brigham and Women’s Hospital

13. Laura Attanasio, PhD, Assistant Professor, School

of Public Health and Health Sciences, University of

Massachusetts Amherst

14. Carrie Atzinger, MS, LGC, CGC, Co-Director, Associate Professor, University of Cincinnati Genetic

Counseling Graduate Program

15. Jennifer Balkus, PhD, MPH, Assistant Professor,

University of Washington School of Public Health

16. Deborah Bartz, MD, MPH, Assistant Professor of

Obstetrics and Gynecology, Harvard Medical School

14a

Appendix

17. Lisa Bayer, MD, MPH, Associate Professor, Department of OB/GYN, Medical Director, Center for Women’s Health, Department of OB/GYN, Associate Fellowship Director, Complex Family Planning, Clinical

Lead, Section of Family Planning, Oregon Health &

Sciences University

18. Jessica Beaman, MD, MPH, Assistant Professor, Department of Medicine, University of California, San

Francisco

19. Candice Belanoff, ScD, MPH, Clinical Associate Professor, Boston University School of Public Health

20. David L. Bell, MD, MPH Professor, Department of

Pediatrics, Department of Population and Family

Health, Columbia University Irving Medical Center

21. Suzanne Bell, PhD, MPH, Assistant Professor, Bill

& Melinda Gates Institute for Population and Reproductive Health, Department of Population, Family,

and Reproductive Health, Johns Hopkins Bloomberg School of Public Health

22. Michael A. Belmonte, MD, Complex Family Planning

Fellow, University of Colorado

23. Karen Benjamin Guzzo, PhD, Director, Center for

Family & Demographic Research, Professor, Department of Sociology, Bowling Green State University

24. Lyndsey Benson, MD, MS, Assistant Professor, Division of Complex Family Planning, Department of Obstetrics and Gynecology, University of Washington

15a

Appendix

25. Chiara Bercu, MPA, Senior Project Manager, Ibis

Reproductive Health

26. Michelle Berlin, MD, MPH, Professor, Oregon

Health & Sciences University Department of Obstetrics & Gynecology and Portland State University

School of Public Health (Emerita), Director, Oregon

Health & Sciences University Center for Women’s

Health (former)

27. Rebecca Berman, MD, FACP, Internal Medicine

Residency Program Director, Professor of Medicine,

University of California, San Francisco

28. Caitlin Bernard, MD, MSCI, Assistant Clinical Professor, Indiana University of Medicine, Department

of Obstetrics and Gynecology

29. Lisa Berry, MS, Licensed Genetic Counselor, Cincinnati Children’s Hospital Medical Center

30. Donald M. Berwick, MD, MPP, Lecturer, Department of Health Care Policy, Harvard Medical School

31. Jonathan Berz, MD, Assistant Professor of Medicine, Boston University School of Medicine

32. Santi KM Bhagat, MD, MPH, Founder and President, Physician-Parent Caregivers

33. Gauri Bhattacharya, PhD/DSW, MSW, MA, LCSW,

ACSW, Former Interim Associate Dean and Full

Professor, Jackson State University, School of Social

Work

16a

Appendix

34. Barbara B. Biesecker, PhD, MS, CGC, Distinguished

Fellow, Health Behavior, Genomics, Ethics and

Translation Program, Genomics, Bioinformatics, and

Translation Division, RTI International

35. Laura Bishop, MD, Associate Program Director, Internal Medicine & Pediatrics Residency Program,

Associate Professor, Departments of Medicine & Pediatrics, University of Louisville

36. Karin J. Blakemore, MD, Professor, Gynecology and

Obstetrics, Director, Prenatal Diagnostic Center,

Johns Hopkins University School of Medicine

37. Janice Blanchard, MD, PhD, Professor, Chief, Health

Policy Section, Department of Emergency Medicine,

The George Washington University

38. Benjamin Blatt, MD, CHSE, Professor of Medicine,

The George Washington University School of Medicine

39. Lynn Blewett, PhD, MA, Professor, Division of

Health Policy and Management, School of Public

Health, University of Minnesota

40. Robert Wm. Blum, MD, MPH, PhD, Principal Investigator, Global Early Adolescent Study, Professor,

Department of Population, Family and Reproductive

Health, John Hopkins Bloomberg School of Public

Health

41. Rachel Bonnema, MD, MS, FACP., Associate Professor of Medicine, University of Texas Southwestern

17a

Appendix

42. Margaret Boozer, MD, MPH, Associate Professor,

Director of Family Planning, Department of OB/

GYN, University of Alabama at Birmingham

43. Christy Boraas, MD, MPH, FACOG, Assistant Professor, Department of OB/GYN/Women’s Health,

University of Minnesota Medical School

44. Eileen Boris, PhD, MA, Hull Professor and Distinguished Professor of Feminist Studies, Distinguished

Professor of History, Black Studies, and Global Studies, University of California, Santa Barbara

45. Liz Borkowski, MPH, Senior Research Scientist,

Managing Director, Jacobs Institute of Women’s

Health, Department of Health Policy and Management, Milken Institute School of Public Health, The

George Washington University

46. Ann Borzecki, MD, Research Associate Professor,

Department of Health Law, Policy & Management,

Boston University School of Public Health

47. Kari P. Braaten, MD, MPH, Assistant Professor of

Obstetrics, Gynecology and Reproductive Biology,

Harvard Medical School

48. Erin Brantley, PhD, MPH, Senior Research Associate, Deputy Director, Center for Health Policy Research, Department of Health Policy and Management, Milken Institute School of Public Health, The

George Washington University

18a

Appendix

49. Carole H. Browner, PhD, MPH, Distinguished Research Professor, Center for Culture and Health, Semel Institute for Neuroscience and Human Behavior,

Department of Anthropology, Department of Gender

Studies, University of California, Los Angeles

50. Alson Burke, MD, Assistant Professor, Department

of Obstetrics and Gynecology, University of Washington

51. Scott Burris, JD, Professor and Director, Center

for Public Health Law Research, Temple University

Beasley School of Law

52. Candace W. Burton, PhD, RN, AFN-BC, AGN-BC,

FNAP, Associate Professor, Sue & Bill Gross School

of Nursing, Director, UCI Forensic Nurse Examiner

Education Program, University of California, Irvine

53. Maureen Byrnes, Teaching Instructor, Department

of Health Policy and Management, The George

Washington University

54. Ealena Callender, MD, FACOG, OB/GYN, Milken

Institute School of Public Health, The George Washington University

55. Katheen Carey, PhD, Professor, Department of

Health Law, Policy and Management, Boston University School of Public Health

56. Maria Casoni, MPH, Senior Research Associate, Department of Health Policy and Management, Milken

19a

Appendix

Institute School of Public Health, The George Washington University

57. Diana Cassady, DrPH, Professor, Public Health Sciences Department, Chair, Graduate Group in Public

Health Sciences, University of California, Davis

58. Paula Castaño, MD, MPH, Associate Professor in

OB/GYN, Columbia University

59. Kathy L. Cerminara, JD, JSD, LLM, Professor of

Law, Shepard Broad College of Law, NSU Florida

60. Rachel Strom Chambers, MPH, Assistant Scientist,

Johns Hopkins University Bloomberg School of Public Health

61. MaryAnn W. Champion, EdD, MS, CGC, Clinical

Professor, Licensed, Certified Genetic Counselor, Director, MS Program in Human Genetics & Genetic

Counseling, Department of Genetics, Stanford University School of Medicine

62. Aileen Chang, MD, MSPH, Associate Professor of

Medicine, The George Washington University School

of Medicine and Health Sciences

63. Brittany M. Charlton, ScD, Assistant Professor, Harvard Medical School and Harvard T.H. Chan School

of Public Health

64. Wendy Chavkin, MD, MPH, Professor of Population and Family Health and Obstetrics-Gynecology

(Emerita), Heilbrunn Department of Population and

20a

Appendix

Family Health and Department of Obstetrics-Gynecology, Mailman School of Public Health and College

of Physicians and Surgeons, Columbia University

65. Reeti Chawla, MD, Attending Physician, Division of

Pediatric Endocrinology, Phoenix Children’s Hospital

66. Angela Y. Chen MD, MPH, FACOG, Family Planning Chief of Service & Fellowship Director, Associate Professor of Obstetrics & Gynecology, David Geffen School of Medicine, University of California, Los

Angeles

67. Kimberly Chernoby, MD, JD, Clinical Instructor of

Emergency Medicine, The George Washington University School of Medicine and Health Sciences

68. Jennifer Chin, MD, Complex Family Planning Fellow, University of Washington

69. Emmeline Chuang, PhD, Associate Professor of

Health Policy and Management, University of California, Los Angeles Fielding School of Public Health

70. Brietta Clark, JD, Associate Dean for Faculty and

Professor of Law, Loyola Law School, Los Angeles

71. Jack A. Clark, PhD, Professor, Health Law, Policy

and Management, Boston University School of Public Health

72. Susan D. Cochran, PhD, MS, Professor of Epidemiology and Statistics, Fielding School of Public Health,

21a

Appendix

University of California, Los Angeles

73. Alan B. Cohen, ScD, Research Professor, Markets,

Public Policy, and Law, Boston University Questrom

School of Business

74. Jessica Cohen, PhD, Associate Professor of Global

Health, Harvard T.H. Chan School of Public Health

75. Megan Cohen, MD, Complex Family Planning Fellow, Instructor, Department of OB/GYN, Oregon

Health & Science University

76. Megan B. Cole, PhD, MPH, Assistant Professor, Department of Health Law, Policy, and Management,

Co-Director, BU Medicaid Policy Lab, Boston University School of Public Health

77. H. Guy Collier, JD, Professor of Practice, University

of Kansas Law School

78. Julia F. Costich, JD, PhD, Peter P. Bosomworth Professor of Health Services Research, Department of

Health Management and Policy, Associate Director,

Ky. Injury Prevention and Research Center, UK College of Public Health

79. Kristine B. Courtney, MS, CGC, Certified Genetic

Counselor, MFM Consultants of Dallas

80. Allison Cowett, MD, MPH, Medical Director, Family

Planning Associates Medical Group, Health Systems

Clinician, Department of Obstetrics and Gynecology,

22a

Appendix

Northwestern University, Feinberg School of Medicine

81. Mitchell Creinin, MD, Professor, Director of Family

Planning, Director, Complex Family Planning Fellowship, Department of Obstetrics and Gynecology,

University of California Davis Health

82. Mary Crossley, JD, Professor of Law, University of

Pittsburgh School of Law

83. Yvette Cuca, PhD, MPH, MIA, Specialist, Community Health Systems, School of Nursing, University

of California, San Francisco

84. Kelly Culwell, MD, MPH, Chief Medical Officer, Afaxys, Inc, Volunteer Clinical Faculty, University of

California, San Diego

85. Carrie Cwiak, MD, MPH, Chief, Obstetrics and

Gynecology, Emory University Hospital Midtown,

Director, Family Planning Division and Fellowship,

Department of Gynecology and Obstetrics, Emory

University School of Medicine

86. Clare Daniel, PhD, Administrative Assistant Professor, Assistant Director of Community Engagement,

Newcomb Institute, Tulane University

87. Philip Darney, MD, MSc, Distinguished Professor,

Emeritus, Department of Obstetrics, Gynecology,

Reproductive Sciences and Health Policy, Director,

Bixby Center for Global Reproductive Health, University of California, San Francisco

23a

Appendix

88. Anne Davis, MD, Wyest-Ayerst Professor of Women’s Health, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center

89. Julianna Deardorff, PhD, Associate Professor, Community Health Sciences Division, School of Public

Health, University of California Berkeley

90. Ana Delgado, CNM, MS, Clinical Professor, UCSF

Department of OB/GYN, University of California,

San Francisco

91. Maria Deloria Knoll, PhD, Senior Scientist, Director,

Epidemiology, International Vaccine Access Center,

Department of International Health, Johns Hopkins

Bloomberg School of Public Health

92. Jennifer Denbow, JD, MPH, Assistant Professor of

Political Science, California Polytechnic State University, San Luis Obispo

93. Colleen Denny, MD FACOG, Medical Director, Ambulatory Women’s Health Services, Bellevue Hospital, Assistant Clinical Professor, Department of Obstetrics and Gynecology, NYU School of Medicine

94. Teresa DePiñeres, MD, MPH, Independent Consultant, Initiatives in Reproductive Health

95. Divya Dethier, MD, Complex Family Planning Fellow, University of Hawaii

96. Kelly K. Dineen, JD, PhD, Associate Professor of

Law, Director, Health Law Program, Creighton University School of Law

24a

Appendix

97. Alesha Doan, PhD, Professor, School of Public Affairs & Administration, Professor, Department of

Women, Gender & Sexuality Studies, University of

Kansas

98. Laura E. Dodge, ScD, MPH, Director of the Division of Research, Assistant Professor, Department

of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School Teaching Hospital and Harvard T.H. Chan School of Public

Health

99. Amy Donahue, MLIS, MGCS, CGC, Certified Genetic Counselor, Associate Professor/Director of Student & Curriculum Inclusion, MS in Genetic Counseling Program, Froedtert & The Medical College of

Wisconsin

100. Karen Donelan, ScD, Stuart H. Altman Professor of

US Health Policy, Heller School of Social Policy &

Management, Brandeis University

101. Greer Donley, JD, Assistant Professor of Law, University of Pittsburgh Law School

102. Jessica K. Douglas, LMSW Associate in the Practice

of C.L. Bockwitz, LPC

103. Monica Dragoman, MD, MPH, Program Director,

Complex Family Planning Fellowship, Department

of Obstetrics, Gynecology, and Reproductive Science,

Icahn School of Medicine at Mount Sinai

25a

Appendix

104. Eleanor Drey, MD, EdM, Acting Chief, ZSFG OBGYN Division, Medical Director, Z.S.F.G. Women’s

Options Center, Professor, Obstetrics, Gynecology

and Reproductive Sciences, University of California,

San Francisco

105. Stephanie Dukhovny, MD, Associate Professor, Director, The Fetal Therapy Program at OHSU Doernbecher Children’s Hospital, Department of Obstetrics & Gynecology - Maternal Fetal Medicine Oregon

Health & Science University

106. Denise M. Dupras, MD, PhD, Associate Professor of

Medicine, Consultant, Primary Care Internal Medicine, Alix School of Medicine, Mayo Clinic

107. Anna Durbin, MD, Professor, International Health,

Johns Hopkins Bloomberg School of Public Health

108. Caryn Dutton, MD, Medical Director, Gynecology

Practice, Brigham and Women’s Hospital

109. Meghan Eagen-Torkko, PhD, CNM, ARNP, FACNM,

Associate Professor & Director of Nursing, School of

Nursing & Health Studies, University of Washington

110. Sarah Rae Easter, MD, Director of Obstetric Critical Care, Division of Maternal-Fetal Medicine, Division of Critical Care Medicine, Brigham and Women’s Hospital, Assistant Professor, Harvard Medical

School

111. Jeffrey L. Ecker, MD, Joe V. Meigs Professor of Ob-

26a

Appendix

stetrics, Gynecology and Reproductive Biology, Harvard Medical School, Chief, Obstetrics and Gynecology, Massachusetts General Hospital

112. Cara L. Eckhardt, PhD, MPH, Associate Professor,

OHSU-PSU School of Public Health

113. Nicole Economou, MD, MPH, Assistant Clinical Professor, UC Davis Health

114. Alison Edelman, MD, MPH, Professor, OB/GYN, Director, Oregon Fellowship in Complex Family Planning, Director, Section of Family Planning, Oregon

Health & Science University

115. Shoshanna Ehrlich, JD, Professor, Women’s, Gender,

and Sexuality Studies, UMass Boston

116. David L. Einsenberg, MD, MPH, FACOG, Associate

Professor, Division of Family Planning, Department

of Obstetrics & Gynecology, Washington University

in St. Louis School of Medicine

117. Alison M. El Ayadi, ScD, MPH, Associate Professor,

Department of Obstetrics, Gynecology and Reproductive Sciences, Department of Epidemiology and

Biostatistics, University of California, San Francisco

118. Erica Eliason, PhD, Postdoctoral Research Fellow,

Brown University School of Public Health

119. Olivia Ellison, MPH, CHES, Rutgers University,

Health Program Analyst, Los Angeles County, Department of Public Health

27a

Appendix

120. Clese Erikson, MPAff, Deputy Director, Health

Workforce Research Center, Fitzhugh Mullan Institute for Health Workforce Equity, Department

of Health Policy and Management, Milken Institute

School of Public Health, The George Washington

University

121. Laura Erskine, PhD, Professor and Director, MPH

Program, Co-Director, UCLA Center for Healthcare

Management, Department of Health Policy and Management, UCLA Fielding School of Public Health

122. Melissa Goldin Evans, PhD, MPH, Postdoctoral Fellow, Tulane University School of Public Health &

Tropical Medicine

123. Daniel S. Goldberg, JD, PhD, Core Faculty, Center

for Bioethics and Humanities, Associate Professor,

Department of Family Medicine, Associate Professor, Department of Epidemiology, University of Colorado Anschutz Medical Campus

124. Katherine Farris, MD, Chief Medical Officer, Planned

Parenthood South Atlantic

125. Linda C. Fentiman, JD, LLM, Professor of Law

Emerita, Elisabeth Haub School of Law, Pace University

126. Kendra Fershee, JD, Professor, Creighton University School of Law

127. Robert I. Field, JD, PhD, MPH, Professor of Law

and Professor of Health Management and Policy,

28a

Appendix

Director, Joint JD/MPH Program, Thomas R. Kline

School of Law and Dornsife School of Public Health,

Drexel University

128. Jonah Fleisher, MD, MPH, FACOG, Assistant Professor Clinical Obstetrics and Gynecology, Director,

University of Illinois at Chicago

129. Chandra L. Ford, PhD, MPH, MLIS, Associate Professor, Department of Community Health Sciences,

Founding Director, Center for the Study of Racism,

Social Justice & Health, Jonathan & Karin Fielding

School of Public Health, University of California,

Los Angeles

130. Jacqueline Fox, JD, LLM, Professor, School of Law,

University of South Carolina

131. Sally Frank, JD, MA, Professor of Law, Drake University

132. David M. Frankford, JD, Professor of Law, Rutgers

University School of Law

133. Beth Fredrick, Senior Associate, Population, Family

and Reproductive Health Department, Johns Hopkins Bloomberg School of Public Health

134. Lynn P. Freedman, JD, MPH, Professor of Population and Family Health at CUIMC, Director, Averting Maternal Death and Disability Program, Columbia University Mailman School of Public Health

29a

Appendix

135. Ann Frisse, MD, Complex Family Planning Fellow,

Department of Obstetrics, Gynecology, and Reproductive Science, Mount Sinai

136. Bianca K. Frogner, PhD, Associate Professor, Department of Family Medicine, Director, Center for

Health Workforce Studies, School of Medicine, University of Washington

137. Erin C. Fuse Brown, JD, MPH, Catherine C. Henson

Professor, Associate Professor of Law, Director, Center for Law, Health & Society, Georgia State University College of Law

138. Lance Gable, JD, MPH, Professor of Law, Wayne

State University Law School

139. Ishani Ganguli, MD, MPH, Assistant Professor of

Medicine, Harvard Medical School

140. Lorena Garcia, MPH, DrPH, Professor, Director,

Undergraduate Education, Department of Public

Health Sciences, Division of Epidemiology, UC Davis

School of Medicine

141. Aileen Gariepy, MD, MPH, MHS, Associate Professor, Associate Chief, Section of Family Planning, Director, Yale Fellowship in Family Planning, Department of Obstetrics, Gynecology, and Reproductive

Sciences, Yale School of Medicine

142. Gail Gazelle, MD, Assistant Professor of Medicine,

Harvard Medical School

30a

Appendix

143. Christina Geddes, Research Assistant, Guttmacher

Institute

144. Stacie Geller, PhD, G William Arends Professor of

Obstetrics and Gynecology, Professor, Division of

Academic Internal Medicine, Department of Medicine, Director, Center for Research on Women and

Gender, College of Medicine, University of Illinois,

Chicago

145. Sherril B. Gelmon, DrPH, Professor of Public

Health, Director, PhD in Health Systems and Policy

Program, Oregon Health & Science University –

Portland State University School of Public Health,

Portland State University

146. Elizabeth Geltman, JD, LLM, Associate Professor, Department of Health Policy and Management,

CUNY Graduate School of Public Health and Health

Policy, Lecturer, Johns Hopkins University, Chair,

APHA Law Section

147. Alison Gemmill, PhD, MPH, Assistant Professor,

Department of Population, Family and Reproductive

Health, Johns Hopkins Bloomberg School of Public

Health

148. Adrienne R. Ghorashi, JD, Program Manager, Center for Public Health Law Research, Temple University, Beasley School of Law

149. S. Monty Ghosh, BSc., MBT, MSc., MD, FRCPC,

DM-EMDM ISAM(C) CSAM, Internal Medicine,

31a

Appendix

Disaster Medicine, and Addiction Medicine, Assistant Professor, Departments of General Internal

Medicine and Neurology, The University of Alberta,

Clinical Assistant Professor, Departments of Medicine and Psychiatry, The University of Calgary

150. Duff Gillespie, PhD, Professor, Bill & Melinda Gates

Institute for Population and Reproductive Health,

Department of Population, Family and Reproductive

Health, Johns Hopkins Bloomberg School of Public

Health

151. Leonard H. Glantz, JD, Emeritus Professor, Health

Law, Policy and Management, Boston University

School of Public Health

152. Emily M. Godfrey, MD, MPH, FAAFP, Associate

Professor, Department of Family Medicine, Research

Section, Department of Obstetrics and Gynecology,

Division of Family Planning, University of Washington

153. Sophie Godley, DrPH, Clinical Assistant Professor,

Boston University School of Public Health

154. Micaela Godzich, MD, Associate Clinical Professor,

Department of Family and Community Medicine,

UC Davis School of Medicine

155. Heather Gold, MD, Family Planning Fellow, OBGYN,

Emory University

156. Alisa B. Goldberg, MD, MPH, Associate Professor

of Obstetrics, Gynecology and Reproductive Biology,

32a

Appendix

Harvard Medical School; Director, Division of Family Planning, Brigham and Women’s Hospital

157. Randy Goldberg, MD, MPH, FACP, Assistant Professor of Clinical Medicine, New York Medical College

158. Noreen J. Goldman, DSc, MSc, MA, Hughes-Rogers

Professor of Demography and Public Affairs, Princeton University

159. Melissa M. Goldstein, JD, Associate Professor, Department of Health Policy and Management, Milken

Institute School of Public Health, The George Washington University

160. Lisa M. Goldthwaite, MD, MPH, Clinical Assistant

Professor of Obstetrics and Gynecology, Stanford

University School of Medicine

161. Cynthia Golembeski, MPH, Robert Wood Johnson

Foundation Health Policy Research Scholar, Rutgers

University/The New School

162. Alexandra M. Goodwin, MD, Clinical Assistant Professor, N.Y.U. Department of General Internal Medicine/Bellevue Hospital

163. Susan Dorr Goold, MD, MHSA, MA, FACP, Professor of Internal Medicine, School of Medicine, Professor of Health Management and Policy, School of Public Health, University of Michigan

164. Pamina M. Gorbach, MHS, DrPH, Professor, Department of Epidemiology, Fielding School of Public

33a

Appendix

Health, Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los

Angeles

165. Sara H. Gordon, PhD, MS, Assistant Professor,

Health Law, Policy, and Management, Co-Director,

BU Medicaid Policy Lab, Boston University School

of Public Health

166. Lawrence Gostin, JD, LLD, University Professor,

Georgetown Law

167. Misasha Suzuki Graham, JD, Social Justice Speaker

and Consultant

168. Kathryn J. Gray, MD, PhD, Attending Physician,

Maternal-Fetal Medicine, Brigham and Women’s

Hospital

169. Pratima Gupta, MD, MPH, Assistant Staff Physician, University of San Diego School of Medicine

170. Bernard Guyer, MD, MPH, Zanvyl Krieger Professor of Children’s Health, Emeritus, Johns Hopkins

Bloomberg School of Public Health

171. Christine L. Hackman, PhD, MCHES, Associate

Professor, Kinesiology & Public Health, California

Polytechnic State University

172. Jill Hagey, MD, MPH, Complex Family Planning

Fellow, Department of Obstetrics and Gynecology,

University of Chapel Hill, North Carolina

34a

Appendix

173. Christine Hake, MS, LCGC, Genetic Counselor, TriState Perinatology, The Women’s Hospital

174. Rebecca W. Hall, JD, Managing Director, Law &

Health Care Program, University of Maryland Francis King Carey School of Law

175. Cassing Hammond, MD, Director, Section and Fellowship in Complex Family Planning, Associate Professor of Obstetrics and Gynecology, Northwestern

Feinberg School of Medicine

176. Arden Handler, DrPH, Professor, Community Health

Sciences, Director, Center of Excellence in Maternal

and Child Health, University of Illinois School of

Public Health

177. Morgan Handley, JD, Research Scientist, Department of Health Policy and Management, Milken Institute School of Public Health, The George Washington University

178. Rachel R. Hardeman, PhD, MPH, Blue Cross Endowed Professor of Health and Racial Equity,

Founding Director, Center for Antiracism Research

for Health Equity, Division of Health Policy & Management, University of Minnesota School of Public

Health

179. Melanie Hardy, MS, MS, CGC, Licensed, Certified

Genetic Counselor, Director, JScreen Genetic Counseling, Department of Human Genetics, Emory University

35a

Appendix

180. Tabetha R. Harken, MD, MPH, Professor of Obstetrics & Gynecology, Division Director of Family Planning, University of California, Irvine

181. Amy R. Harrington, MD, Associate Professor, Obstetrics & Gynecology, URMC Family Planning, Residency Program Director, Obstetrics & Gynecology,

University of Rochester Medical Center

182. Steven A. Harvey, PhD, Associate Professor, Social

and Behavioral Interventions Program, Department

of International Health, Johns Hopkins Bloomberg

School of Public Health

183. Mark Hathaway, MD, MPH, Medical Director, Sr.

Technical Advisor for Reproductive Health and Family Planning, Adjunct Assistant Professor in Gynecology and Obstetrics, Johns Hopkins University

184. Daniel R. Hawkins, Senior Vice President for Public Policy (ret.), National Association of Community

Health Centers

185. Elizabeth Hazel, PhD, Assistant Scientist, International Health Department, Johns Hopkins Bloomberg School of Public Health

186. Amanda Heffernan, MSN, CNM, Instructor, Seattle

University College of Nursing

187. Janet Heinrich, DrPH, RN, FAAN, Research Professor, Department of Health Policy and Management, Milken Institute School of Public Health, The

George Washington University

36a

Appendix

188. Lori Heise, PhD, Professor, Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health

189. Yaniv Heled, JSD, Professor of Law, Co-Director,

Center for Intellectual Property, Center for Law,

Health & Society, Georgia State University College

of Law

190. Jillian T. Henderson, PhD, MPH, Investigator, Kaiser Permanente, Northwest, Center for Health Research, KP Evidence-Based Practice Center

191. Catherine Hennessey, MD, Family Planning Fellow,

University of Chicago

192. Luciana E. Herbert, PhD, Assistant Professor, Institute for Research and Education to Advance Community Health (IREACH), Department of Medical

Education and Clinical Sciences, Elson S. Floyd College of Medicine, Washington State University

193. Laura Hercher, MS, CGC, Director of Student Research, Sarah Lawrence College Joan H. Marks

Graduate Program in Human Genetics

194. Laura Hermer, JD, LLM, Professor of Law, Mitchell

Hamline School of Law

195. Stephanie Herold, MPH, Data Analyst, Advancing

New Standards in Reproductive Health, University

of California, San Francisco

37a

Appendix

196. Alyssa R. Hersh, MD, MPH, Resident Physician,

Department of Obstetrics & Gynecology, Oregon

Health & Science University

197. Jennifer Hickey, JD, Postdoctoral Fellow, Vulnerability and the Human Condition Initiative, Emory University School of Law

198. Stacy Higgins, MD, Professor of Medicine, Emory

University School of Medicine

199. Vivian Ho, PhD, Director, Center for Health and Biosciences, Baker Institute, Professor, Department of

Economics, Professor, Baylor College of Medicine,

Rice University Department of Economics

200. Tricia A. Hoefling, JD, Adjunct Professor, Georgetown Law

201. Diane E. Hoffmann, JD, Jacob A. France Professor

of Health Law, Director, Law & Health Care Program, University of Maryland Carey School of Law

202. E. Alison Holman, PhD, FNP., Associate Professor,

Sue & Bill Gross School of Nursing, University of

California, Irvine

203. Kelsey Holt, ScD, MA, Assistant Professor, Department of Family & Community Medicine, School of

Medicine, University of California, San Francisco

204. Katherine Horton, RN, MPH, JD, Research Professor in the Department of Health Policy and Management, Milken Institute School of Public Health, The

George Washington University

38a

Appendix

205. April Hovav, PhD, Post-Doctoral Scholar, Urban &

Environmental Policy Department, Occidental College

206. Nicole Huberfeld, JD, Edward R. Utley Professor

of Health Law, Boston University School of Public

Health, Professor of Law, Boston University School

of Law

207. Margy Hutchison, CNM, Clinical Professor, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco

208. Rachel Bender Ignacio, MD, MPH, Assistant Professor, Division of Allergy and Infectious Diseases,

Department of Medicine, University of Washington

209. Lisa C. Ikemoto, JD, LLM, Martin Luther King, Jr.

Professor, University of California, Davis School of

Law

210. Sara Imershein, MD, MPH, FACOG, Clinical Professor OB-GYN, The George Washington University

School of Medicine and Health Sciences

211. Luu Ireland, MD, MPH, FACOG, Assistant Professor of Obstetrics and Gynecology, OB/GYN Director

of Diversity, Equity and Inclusion, MA-ACOG Legislative Chair, UMass Memorial Medical Center

212. Adam Jacobs, MD, Medical Director, Division of

Family Planning Mount Sinai Health System, Medical Director Family Planning, Bronxcare Medical

Center, Associate Professor, OB/GYN, Pediatrics,

39a

Appendix

and Medical Education, Icahn School of Medicine,

Mount Sinai

213. David Jacobson, MD, FACP, Program Director, Internal Medicine Residency, Santa Clara Valley Medical Center, Clinical Associate Professor (Affiliated),

Stanford University School of Medicine, Clinical Associate Professor of Medicine, Geisel School of Medicine

214. Peter D. Jacobson, JD, MPH, Professor Emeritus

of Health Law and Policy, University of Michigan

School of Public Health

215. Ruvani Jayaweera, PhD, MPH, Senior Associate Research Scientist, Ibis Reproductive Health

216. Sheara Jennings, PhD, MSW, Associate Professor

and Humana Endowed Chair in Social Determinants

of Health, Faculty Advisor—Association of Black

Social Workers, GCSW-UH Chapter, University of

Houston Graduate College of Social Work

217. Dana M. Johnson, MPAff, Lyndon B. Johnson School

of Public Affairs, The University of Texas at Austin

218. Kay A. Johnson, MPH, EdM, President, Johnson

Group Consulting, Inc.

219. Timothy R.B. Johnson, MD, FACOG, Arthur F. Thurnau Professor of Obstetrics and Gynecology, Professor of Women’s Studies, Founder, Michigan Medicine

Women’s Health Program, University of Michigan

40a

Appendix

220. Jon Kingsdale, PhD, Associate Professor of the

Practice, Health Law, Policy & Management, Boston

University School of Public Health

221. Heidi E. Jones, PhD, MPH, Director, Doctoral Program in Epidemiology, Associate Professor, Department of Epidemiology & Biostatistics, CUNY School

of Public Health

222. Timothy S. Jost, JD, Emeritus Professor, Washington and Lee University School of Law

223. Chava Kahn, MD, MPH, Interim Director of Surgical Services, Planned Parenthood of Maryland

224. James G. Kahn, MD, MPH, Professor of Health

Policy, Epidemiology, and Global Health, Phillip R.

Lee Institute for Health Policy Studies, University

of California, San Francisco

225. Jennifer Kaiser, MD, Assistant Professor, OBGYN,

University of Utah

226. Sapna Kalsy, MD, MPH, Physician, Planned Parenthood Southwest Ohio

227. Deborah Kamali, MD, Associate Professor, Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco Women’s Health

228. Bliss Kaneshiro, MD, MPH, Professor, University of

Hawaii Johns A. Burns School of Medicine

229. Farzana Kapadia, PhD, MPH, Associate Professor of

Epidemiology & Population Health, Deputy Editor,

41a

Appendix

AJPH, New York University School of Global Public

Health

230. Sherrie H. Kaplan, PhD, MPH, Professor of Medicine and Anesthesiology & Perioperative Care, Assistant Vice Chancellor, Healthcare, Evaluation and

Measurement, University of California Irvine School

of Medicine

231. Beth Y. Karlan, MD, Vice Chair, Women’s Health

Research, Professor, Department of Obstetrics and

Gynecology, Director, Cancer Population Genetics,

Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los

Angeles

232. Jennifer Karlin, MD, PhD, Assistant Professor &

Associate Director, Predoctoral Education Program,

Department of Family & Community Medicine, UC

Davis Health System

233. Ruth A. Karron, MD, Professor, International Health,

Director, Center for Immunization Research, Director, Johns Hopkins Vaccine Initiative, Johns Hopkins

Bloomberg School of Public Health

234. Jodie G. Katon, PhD, MS, Assistant Research Professor, Department of Health Systems and Population Health, University of Washington

235. Ingrid Katz, MD, MHS., Assistant Professor of Medicine, Harvard Medical School

42a

Appendix

236. Joanne Katz, ScD, Professor, Global Disease Epidemiology and Control Program, Department of International Health, Johns Hopkins Bloomberg School of

Public Health

237. Judith R. Katzburg, PhD, MPH, RN, Health Services Researcher, Past Chair, Maternal & Child Health

Section, American Public Health Association

238. Georgia Kayser, PhD, Assistant Professor, Division

of Global Health, Family Medicine and Public Health,

The School of Medicine, University of California, San

Diego

239. Nancy L. Keating, MD, MPH, Professor of Health

Care Policy and Medicine, Harvard Medical School

240. Lynn Kersey, MA, MPH., CLE, Executive Director,

Maternal and Child Health Access

241. Stacie Kershner, JD, Associate Director, Center for

Law, Health & Society, Georgia State University College of Law

242. Thomas Kibby, MD, MPH, Program Director, Preventive Medicine Residency, Washington University

School of Medicine

243. Marielle R. Kirstein, Senior Research Assistant,

Guttmacher Institute

244. Patricia Kissinger, PhD, MPH, BSN, Professor of

Epidemiology, Tulane University School of Public

Health and Tropical Medicine

43a

Appendix

245. Jennifer Ko, Project Director, Advancing New Standards in Reproductive Health, Bixby Center for

Global Reproductive Health, University of California, San Francisco

246. Jennifer Koch, MD, FACP, Professor of Medicine,

Program Director, Internal Medicine Residency,

University of Louisville

247. Melissa Kottke, MD, MPH, MBA, Associate Professor, Department of Gynecology and Obstetrics, Emory University School of Medicine

248. Nancy Krieger, PhD, Professor of Social Epidemiology, American Cancer Society Clinical Research

Professor, Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health

249. Claudia Kroker-Bode, MD, PhD, FACP, Director, Internal Medicine Residency Florida State University,

Professor, Clinical Sciences Florida State University

College of Medicine

250. Randall Kuhn, PhD, MA, Associate Professor, Department of Community Health Sciences, University

of California, Los Angeles Fielding School of Public

Health

251. Elizabeth Kukura, JD, LLM, MSc, Assistant Professor of Law, Thomas R. Kline School of Law, Drexel

University

252. Taylor M. Kupneski, MS, CGC Genetics Counselor,

LabCorp Women’s Health and Genetics

44a

Appendix

253. Andrea Z. LaCroix, PhD, Professor and Chief of

Epidemiology, Director, Women’s Health Center of

Excellence, Family Medicine and Public Health, University of California, San Diego

254. Emily Lancaster, MS, CGC, Licensed Certified

Counselor, Division of Genetic and Genomic Medicine, UPMC Children’s Hospital of Pittsburgh

255. Renée M. Landers, JD, Professor of Law and Faculty Director, Health and Biomedical Law Concentration, Suffolk University Law School

256. Roxanne M. Landis, JD, MPH, Director of Policy,

Ryan Residency Training Program, Bixby Center for

Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco

257. Bruce E. Landon, MD, MBA, MSc, Professor of

Health Care Policy, Harvard Medical School, Professor of Medicine, Beth Israel Deaconess Medical

Center

258. Uta Landy, PhD, Senior Advisor, University of California, San Francisco, Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology, and Reproductive Sciences

259. Valerie J. Lang, MD, MHPE, Associate Professor of

Medicine, Senior Associate Division Chief, Hospital

Medicine Division, Director, Faculty Development,

Associate Director, University of Rochester School

of Medicine & Dentistry

45a

Appendix

260. Ana Langer, MD, Professor of the Practice of Public

Health, Coordinator of the Dean’s Special Initiative

on Women and Health, Department of Global Health

and Population, Harvard T.H. Chan School of Public

Health

261. Paula Lantz, PhD, James B. Hudak Professor of

Health Policy, Professor of Public Policy, Gerald R.

Ford School of Public Policy, Professor of Health

Management and Policy, School of Public Health,

University of Michigan

262. Peter LaPuma, PhD, CIH, PE, Professor, Department of Environmental and Occupational Health,

Miken Institute School of Public Health, The George

Washington University

263. Karen E. Lasser, MD, MPH, Professor of Medicine,

Boston Medical Center, Boston University School of

Medicine

264. Kacia Lee, MD, Assistant Professor of Medicine,

University of Minnesota Medical School

265. Arleen A. Leibowitz, PhD, Professor Emeritus and

Research Professor, UCLA Luskin School of Public

Affairs

266. Katie Leonard, FNP-BC, Nurse Practitioner, Adolescent Medicine, BC4U Family Planning, University of Colorado School of Medicine

267. Elli Leontsini, MD, MPH, Associate Scientist, Social

and Behavioral Interventions, Department of Inter-

46a

Appendix

national Health, Johns Hopkins Bloomberg School of

Public Health

268. Julea Leshar McGhee, MD, MPH, Clinical Assistant

Professor of Psychiatry & Biobehavioral Sciences,

David Geffen School of Medicine at UCLA

269. Jeffrey Levi, PhD, Professor of Health Policy and

Management, Milken Institute School of Public

Health, The George Washington University

270. Adam Levy, MD, Associate Professor, OB/GYN,

Ryan Program Director, UNLV School of Medicine

271. Amy B. Lewin, PsyD, Associate Professor, Family

Science, University of Maryland School of Public

Health

272. Demar F. Lewis IV, MPP, RWJF Health Policy Research Scholar, Yale University

273. Annie Lewis-O’Connor, PhD, NP, MPH, Instructor in

Medicine, Harvard Medical School, Founder and Director, C.A.R.E. Clinic-Brigham and Women’s Hospital

274. Abigail Liberty, MD, MSPH, Complex Family Planning Fellow, Department of Obstetrics & Gynecology,

Oregon Health & Science University

275. Jessica Liddell, PhD, MSW, MPH, Assistant Professor, School of Social Work, University of Montana

276. Marsha Lillie-Blanton, DrPH, Associate Research

Professor, Department of Health Policy and Manage-

47a

Appendix

ment, Milken Institute School of Public Health, The

George Washington

277. Elie Losleben, MPH, Co-Founder, Code Innovation

LLC

278. Julie Loza, MD, Assistant Professor of Clinical Family Medicine, Department of Family and Community

Medicine, University of Illinois at Chicago

279. Frey Lund Sonenstein, PhD, Professor Emerita,

Johns Hopkins Bloomberg School of Public Health

280. Katherine Lupton, MD, FACP, Associate Professor

of Medicine, University of California School of Medicine

281. Lauren Maclvor Thompson, PhD, Faculty Research

Fellow, Center for Law, Health, Society, Georgia

State University College of Law, Assistant Professor

of History and Interdisciplinary Studies, Kennesaw

State University

282. Paris Maloof-Bury, MSN, CNM, RNC-OB, IBCLC,

President, California Nurse-Midwives Association

283. Laura Mamo, PhD, Health Equity Institute Professor of Health Education, San Francisco State University

284. Maya Manian, JD, Visiting Professor American University Washington College of Law

48a

Appendix

285. Constance Mao, MD, Associate Professor Emeritus,

Department of Obstetrics and Gynecology, University of Washington Harborview Medical Center

286. Wendy K. Mariner, JD, LLM, MPH, Professor

Emerita, Health Law, Ethics, and Human Rights,

Boston University School of Public Health

287. Nicholas Mark, MA, Institute for Education Sciences – Predoctoral Interdisciplinary Training Fellow,

New York University

288. Melissa L. McCarthy, ScD, MS, Professor of Health

Policy and Emergency Medicine, Milken Institute

School of Public Health, The George Washington

University

289. Lois McCloskey, DrPH, MPH, Associate Professor,

Director, Center of Excellence in Maternal and Child

Health, Department of Community Health Sciences,

Boston University School of Public Health

290. K. John McConnell, PhD, Director, Center for Health

Systems Effectiveness, Professor, Department of

Emergency Medicine, Oregon Health & Science University

291. Sabrina McCormick, PhD, Associate Professor,

Department of Environmental and Occupational

Health, Milken Institute School of Public Health,

The George Washington University

292. Molly McNulty, JD, Assistant Professor of Public

Health Law & Policy, University of Rochester

49a

Appendix

293. Darcy M. Meals, JD, Assistant Director, Center for

Access to Justice, Georgia State University College

of Law

294. Karen Meckstroth, MD, MPH, Professor, Department of Obstetrics, Gynecology, and Reproductive

Sciences, University of California, San Francisco

295. Joy Melnikow, MD, MPH, Professor, Department of

Family and Community Medicine, Director, Center

for Healthcare Policy and Research, University of

California, Davis

296. Terrie Mendelson, MD, FACP, Director, Graduate

Medical Education, Designated Institutional Official for ACGME, Dignity Health St. Mary’s Medical

Center San Francisco, Chair, Common Spirit Health

GME Leadership Council, Associate Professor of

Medicine, UCSF

297. Ruth B. Merkatz, PhD, RN, FAAN, Clinical Professor, Department of Obstetrics and Gynecology and

Women’s Health, Albert Einstein College of Medicine, Senior Clinical Scientist, Center for Biomedical

Research, Population Council

298. Sarah Merriam, MD, MS, Clinical Assistant Professor of Medicine, Division of General Internal Medicine, VA Pittsburgh Healthcare System

299. David Michaels, PhD, MPH, Professor, Department

of Environmental and Occupational Health, Milken

Institute School of Public Health, The George Washington University

50a

Appendix

300. Lisa Mihaly, FNP-BC, RN, Assistant Clinical Professor, Family Nurse Practitioner Program, Department of Family Health Care Nursing, School of

Nursing, University of California, San Francisco

301. Velvet G. Miller, PhD, FAAN, Adjunct Assistant Professor Ret., Obstetrics and Gynecology Department,

Indiana University School of Medicine

302. Howard Minkoff, MD, Distinguished Professor Obstetrics and Gynecology, SUNY Downstate and Maimonides Medical Center

303. Ana Mónica Yepes-Ríos, MD, FACP, Associate Professor, Department of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western University

304. Jim Montoya, MD, FACEP, FAAEM, Emergency

Physician, Chief, Department of Emergency Medicine, Sutter Medical Center Sacramento

305. Michelle Moore, MS, CGC, Senior Lab Genetic Counselor, Sanford Imagenetics

306. Caroline Moreau, MD, PhD, Associate Professor,

Population Family and Reproductive Health, Johns

Hopkins School of Public Health

307. Kathleen Morrell, MD, MPH, Director of Family Planning Division, Residency Program Director,

Maimonides Medical Center, Department of Obstetrics & Gynecology

51a

Appendix

308. Meghan D. Morris, PhD, MPH, Assistant Professor,

Department of Epidemiology & Biostatistics, School

of Medicine, University of California, San Francisco

309. Rebecca Morris, MPP, Research Associate, Department of Health Policy and Management, Milken Institute School of Public Health, The George Washington University

310. Elizabeth A. Mosley, PhD, MPH, Clinical Assistant

Professor, Georgia State University

311. Ulrike Muench, PhD, RN, FAAN, Assistant Professor, Co-Director Health Policy Specialty, Department

of Social & Behavioral Sciences, School of Nursing,

Philip R. Lee Institute for Health Policy Studies,

University of California, San Francisco

312. Caitlin Murphy, MPA-PNP, Senior Research Associate, Department of Health Policy and Management,

Milken Institute School of Public Health, The George

Washington University

313. Jennifer Musick, MPH, Professor, Health Education

Department, Long Beach City College

314. Ashley Navarro, MD, MPH, Complex Family Planning Fellow and OBGYN, University of North Carolina Chapel Hill

315. Sara Newmann, MD, MPH, Associate Professor, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco

52a

Appendix

316. Mark Nichter, PhD, MPH, Regents Professor

Emeritus, School of Anthropology, College of Public

Health, University of Arizona

317. Oroma Nwanodi, MD, DHSc, FACOG, Section Councilor, APHA SRH Section and Governing Councilor,

APHA FN Section, Obstetric Hospitalist, Mednax/

Magella Medical Group

318. Alec B. O’Connor, MD, MPH, William Morgan Professor of Medicine, Director, Internal Medicine Residency Program, University of Rochester School of

Medicine

319. Damara Ortiz, MD, FAAP, FACMGG, Assistant

Professor of Pediatrics, Director, Lysosomal Storage Disorders Program, Program Director, Medical

Genetics Residency, Medical Director, Genetic Counselor Training Program, Medical Genetics/PKU Department, UPMC Children’s Hospital of Pittsburgh

320. Laura Ozark, MD, FACP, Clinical Associate Professor, Associate Program Director, Internal Medicine

Residency, Loyola University Medical Center

321. Lydia E.W. Pace, MD, MPH, Associate Physician,

Division of Women’s Health, Brigham and Women’s

Hospital, Director of Women’s Health Policy and

Advocacy, Connors Center for Women’s Health and

Gender Biology, Brigham and Women’s Hospital,

Assistant Professor of Medicine, Harvard Medical

School

53a

Appendix

322. Robert Pargament, MD, FACP, General Internist,

Internal Medicine Residency Program Director,

WellSpan York Hospital

323. Ina Park, MD, MS, Associate Professor, Department

of Family and Community Medicine, University of

California San Francisco School of Medicine

324. Wendy E. Parmet, JD, Matthews Distinguished University Professor of Law and Director, Center for

Health Policy and Law, Professor of Public Policy

and Urban Affairs, Northeastern University School

of Public Policy and Urban Affairs

325. Ashlesha Patel, MD, MPH, MsHQS, System Chair

of Family Planning Services, Department of Obstetrics & Gynecology, Cook County Health, Professor,

Department of Obstetrics & Gynecology, Feinberg

School of Medicine, Northwestern University

326. Rajita Patil, MD, FACOG, Assistant Clinical Professor, Department of Obstetrics and Gynecology, David

Geffen School of Medicine, University of California,

Los Angeles.

327. Benjamin Patterson Brown, MD, MS, Assistant Professor, Clinician Educator, Division of General Obstetrics and Gynecology, Department of Obstetrics

and Gynecology, Alpert Medical School of Brown

University

328. Melissa E. Paulen, MD, MPH, Staff Physician,

Planned Parenthood Great Northwest, Hawaii, Alaska, Indiana, Kentucky

54a

Appendix

329. Marit Pearlman Shapiro, MD, MPH, Complex Family Planning Fellow, University of Hawai’i

330. Sayida Peprah, PsyD, Licensed Clinical Psychologist

and Maternal Mental Health Consultant, Rancho

Cucamonga, California

331. James M. Perrin, MD, Professor of Pediatrics,

Harvard Medical School, John C. Robinson Distinguished Chair in Pediatrics, MassGeneral Hospital

for Children

332. Rachel Perry, MD, MPH, Associate Professor of Obstetrics and Gynecology, University of California, Irvine

333. Mark A. Peterson, MD, Professor of Public Policy,

Political Science, and Law, University of California

Los Angeles, Luskin School of Public Affairs

334. Jennifer Piatt, JD, Research Scholar, Center for

Public Health Law and Policy, Sandra Day O’Connor

College of Law, Arizona State University

335. Rachel Pilliod, MD, Managing Director, Oregon

Perinatal Collaborative, Associate Program Director, Maternal Fetal Medicine Fellowship, Assistant

Professor, Maternal Fetal Medicine, Oregon Health

& Science University

336. Christie Pitney, CNM, WHNP, Forward Midwifery,

Nursing, and Reproductive Health

337. Patricia Pittman, PhD, Professor of Health Policy

and Management, Director, Health Workforce Re-

55a

Appendix

search Center, Milken Institute School of Public

Health, The George Washington University

338. Jennifer L. Pomeranz, JD, MPH, Assistant Professor, Department of Public Health Policy and Management, School of Global Health, New York University

339. Ninez A. Ponce, PhD, Director, UCLA Center for

Health Policy Research, Professor, Department of

Health Policy and Management, UCLA Fielding

School of Public Health

340. Sarah Prager, MD, MAS, Professor of Obstetrics and

Gynecology and Director of the Fellowship in Complex Family Planning, University of Washington

341. Linda Prine, MD, FAAFP, Professor of Family and

Community Medicine, Mt. Sinai School of Medicine

342. Sharon A. Rachel, MA, MPH, Associate Project Director, Satcher Health Leadership Institute, Morehouse School of Medicine

343. Anita Raj, PhD, MS, Tata Chancellor Professor of

Society and Health, Professor of Medicine, Professor of Education Studies, Director, Center on Gender Equity and Health, University of California, San

Diego

344. Astha Ramaiya, DrPH, Research Associate, Global

Early Adolescent Study, Department of Population,

Family and Reproductive Health, Johns Hopkins

Bloomberg School of Public Health

56a

Appendix

345. Aparna R. Ramanathan, MD, MPH, Assistant Professor, Department of Obstetrics and Gynecology,

University of Illinois at Chicago

346. Misha Rashkin, MS, CGC, Certified Genetic Counselor, Stanford Cancer Center

347. Elizabeth Reed, ScD, MPH, Associate Professor of

Global Health, Co-Director, SDSU-UCSD Global

Health Joint Doctoral Program, Division of Health

Promotion and Behavioral Science, Graduate School

of Public Health, San Diego State University

348. Susan D. Reed, MD, MPH, Professor and Vice Chair,

Department of Obstetrics and Gynecology, Adjunct,

Department of Epidemiology, Program Director,

Women’s Reproductive Health Research Program,

University of Washington School of Medicine

349. Matthew Reeves, MD, MPH, FACOG, Executive Director, DuPont Clinic, Clinical Associate Professor of

Obstetrics and Gynecology, George Washington University School of Medicine and Health Sciences, Adjunct Clinical Associate Professor of Obstetrics and

Gynecology, Stanford University School of Medicine,

Adjunct Associate Professor of Population, Family,

and Reproductive Health, Johns Hopkins Bloomberg School of Public Health

350. Marsha Regenstein, PhD, Professor, Department of

Health Policy and Management, The George Washington University

57a

Appendix

351. Jennifer Reich, PhD, Professor, University of Colorado Denver

352. Jessica Reid, MD, MCR, Assistant Professor, Oregon Health & Sciences University

353. Kathryn M. Rexrode, MD, MPH, Chief, Division of

Women’s Health, Brigham and Women’s Hospital

354. Thomas Rice, PhD, Professor, Department of Health

Policy and Management, UCLA Fielding School of

Public Health

355. Adam K. Richards MD, PhD, MPH, DTM&H, Associate Professor, Department of Global Health,

Milken Institute School of Public Health, Department of Medicine, School of Medicine and Health

Science, The George Washington University

356. Janet Rich-Edwards, ScD, MPH, Associate Professor of Medicine, Harvard Medical School, Associate Professor in Epidemiology, Harvard T.H. Chan

School of Public Health

357. Thomas C. Ricketts, PhD, MPH, Senior Policy Fellow, Cecil G. Sheps Center for Health Services Research, Professor of Health Policy and Management

and Social Medicine, The University of North Carolina at Chapel Hill

358. Richard Riegelman, MD, MPH, PhD, Professor of

Epidemiology and Biostatistics and Founding Dean,

Milken Institute School of Public Health, The George

Washington University

58a

Appendix

359. Eve Rittenberg, MD, Assistant Professor of Medicine, Harvard Medical School

360. Maria I. Rodriguez, MD, MPH, Associate Professor,

Obstetrics & Gynecology, Center for Health Systems

Effectiveness, Oregon Health & Science University

361. Deborah Rogow, MPH, Reproductive Health Policy

Analyst, Independent Consultant

362. Theresa Rohr-Kirchgraber, MD, FACP, FAMWA,

Professor of Clinical Medicine, Assistant Director of

Community & Population Health, AU/UGA Medical

Partnership, University of Georgia

363. Joanne Rosen, JD, MA, Senior Lecturer, Associate

Director, Center for Law and the Public’s Health,

Johns Hopkins Bloomberg School of Public Health

364. Ellen Rosenbaum, MPH, Data Coordinator, Sexual

and Reproductive Health Services, Health Imperatives

365. Sara Rosenbaum, JD, Harold and Jane Hirsh Professor of Health Law and Policy, Department of Health

Policy and Management, Milken Institute School of

Public Health, The George Washington University

366. David Rosenbloom, PhD, Professor of Public Health,

Boston University School of Public Health

367. Rita Rossi-Foulkes, MD, FAAP, MS, FACP, Program

Director, University of Chicago Internal MedicinePediatrics Residency, Associate Professor of Inter-

59a

Appendix

nal Medicine and Pediatrics, University of Chicago

Medicine

368. Brita Roy, MD, MPH, MHS, Assistant Professor of

Medicine, Director of Population Health, Yale University School of Medicine

369. Dorit Rubinstein Reiss, PhD, LLB, Professor Law,

UC Hastings College of the Law

370. Aliye Runyan, MD, OBGYN, Westchester Medical

Center, New York

371. Jennefer Russo, MD, MPH, Vice Chair of Clinical Affairs, Department of OBGYN, Harbor-UCLA Medical Center, Associate Clinical Professor, UCLA

372. Iris Ryn Olson, MPH, Center Manager, Center for

Women’s Health Research and Innovation, University of Pittsburgh

373. Tina K. Sacks, PhD, Assistant Professor, School of

Social Welfare, University of California at Berkeley

374. Sally Safi, PhD, MSPH, Senior Technical Advisor

for Capacity Building, PMA-Ethiopia, Bill and Melinda Gates Institute for Population and Reproductive Health, Department of Population, Family, and

Reproductive Health, Johns Hopkins Bloomberg

School of Public

375. Katelynn G. Sagaser, MS, CGC, Assistant Professor,

Department of Gynecology and Obstetrics, Johns

Hopkins University School of Medicine, Certified

60a

Appendix

Genetic Counselor, Johns Hopkins Hospital, Prenatal Diagnosis & Treatment Center

376. William M. Sage, MD, JD, James R. Dougherty

Chair for Faculty Excellence, School of Law, Professor of Surgery and Perioperative Care, Dell Medical

School, The University of Texas at Austin

377. Carolina Salmeron, MPH, Senior Project Director,

Texas Campaign to Prevent Teen Pregnancy

378. Gopal Sankaran, MD, DrPH, MNAMS, CHES, Professor of Public Health, Department of Health, College of Health Sciences, West Chester University

379. Ani B. Satz, JD, PhD, Professor of Law and Public

Health, Project Leader, Health Law, Policy & Ethics Project, Affiliated Professor of Business, Senior

Faculty Fellow, Center for Ethics, Faculty Fellow,

Emory Global Health Initiative, Emory University

School of Law

380. Nadia N. Sawicki, JD, M. Bioethics, Georgia Reithal

Professor of Law, Co-Director, Beazley Institute for

Health Law and Policy, Loyola University Chicago

School of Law

381. Robyn Schickler, MD, MSc, OB/GYN Physician,

Planned Parenthood of Southwest and Central Florida

382. Elizabeth Schroeder, MPH, Program Officer, Heilbrunn Department of Population and Family Health,

61a

Appendix

Columbia University Mailman School of Public

Health

383. Eleanor Bimla Schwarz, MD, MS, FACP, Chief, Division of General Internal Medicine, Zuckerberg

San Francisco General Hospital and Trauma Center,

Professor of Medicine, University of California, San

Francisco School of Medicine

384. Jessica Sebastian, MS, CGC, Certified and Licensed

Genetic Counselor, III, UPMC Children’s Hospital

of Pittsburgh

385. Dominika Seidman, MD, MA, Assistant Professor,

Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco

386. Elissa Serapio, MD, MPH, Clinical Fellow, University of California, San Francisco School of Medicine

387. Paul Shafer, PhD, Assistant Professor, Department

of Health Law, Policy, and Management, Boston University School of Public Health

388. Brandi Shah, MD, MPH, Assistant Professor, Family

and Community Medicine, University of AlabamaBirmingham

389. Holly Shakya, PhD, Assistant Professor, Department of Medicine, Division Global Public Health,

University of California, San Diego

390. Anita Shankar, Associate Scientist, Johns Hopkins

University, Bloomberg School of Public Health

62a

Appendix

391. Lauren Shapiro, MD, Program Director Internal

Medicine Residency Program, Associate Professor

of Medicine, Montefiore Medical Center, The University Hospital for Albert Einstein College of Medicine

392. Peter Shin, PhD, MPH, Associate Professor, Department of Health Policy and Management, The George

Washington University

393. Steven Shoptaw, PhD, Professor and Vice Chair for

Research, Department of Family Medicine, David

Geffen School of Medicine, University of California,

Los Angeles

394. Darby Sider, MD, FACP, FAAP, Vice-Chair of Internal Medicine, Program Director, Internal Medicine

Residency, Graduate Medical Education, Cleveland

Clinic Florida

395. Jessica Silbey, PhD, JD, Professor of Law and

Yanakakis Faculty Research Scholar, Boston University School of Law

396. Diana Silver, PhD, MPH, Associate Professor of

Global Public Health and Public Health Policy, CoDirector, Public Health Policy Lab, School of Global

Public Health, New York University

397. Jay Silverman, PhD, Professor of Medicine and

Global Public Health, University of California San

Diego School of Medicine

398. Diane Simeoni, MS, Certified Genetic Counselor, Envision Healthcare

63a

Appendix

399. Michael S. Sinha, MD, JD, MPH, Adjunct Faculty,

Northeastern University School of Law, Visiting

Scholar, NUSL Center for Health Policy and Law

400. Gretchen Sisson, PhD, Research Sociologist, Department of Obstetrics, Gynecology, and Reproductive Science, University of California, San Francisco

401. Michelle Skaer Therrien, MPH, Global Project Director, Bixby Center for Global Reproductive Health,

University of California San Francisco

402. Emily R. Smith, ScD, MPH, Assistant Professor, Departments of Global Health & Exercise & Nutrition

Sciences, Milken Institute School of Public Health,

The George Washington University

403. Sarita Sonalkar, MD, MPH, Assistant Professor of

Obstetrics and Gynecology, Division of Family Planning, University of Pennsylvania Health System

404. Stephanie Spaulding, MGC, LCGC, Genetic Counselor, Genetics Department, Kaiser Permanente

405. Sally Stearns, PhD, Professor, Department of Health

Policy and Management, The University of North

Carolina at Chapel Hill

406. Joanne Stekler, MD, MPH, Associate Professor,

Division

of

Infectious

Diseases

Adjunct Associate Professor, Epidemiology and

Global Health, University of Washington

407. Blair Stevens, MS, CGC, Assistant Professor, Director, Prenatal Genetic Counseling Services, Depart-

64a

Appendix

ment of Obstetrics, Gynecology and Reproductive

Sciences, UTHealth McGovern Medical School

408. Melissa Stillman, MPH, Senior Research Associate,

Guttmacher Institute

409. Jamila K. Stockman, PhD, MPH, Vice Chief, Global

Public Health Section, Associate Professor, Director,

CFAR, Disparities Core, Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California, San Diego

410. Melissa Stockwell, MD, MPH, FAAP, Chief, Division

of Child and Adolescent Health, Director, Center

for Children’s Digital Health Research, Associate

Professor of Pediatrics and Population and Family

Health, Department of Pediatrics, College of Physicians & Surgeons, Department of Population and

Family Health, Mailman School of

This text is long and has been trimmed here. Open the source document for the complete record.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.